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ABSTRACT 
In the investigations described in this thesis I have examined various 
mechanisms involved in transcriptional control. The first chapter is a general 
examination of the mechanisms used in transcriptional control. The second 
chapter addresses issues associated with the selection of transcriptional start 
site. This work shows that core promoter usage can be altered in a tissue-
specific and environmentally-responsive manner. The third chapter of this 
work describes a significant improvement in the technique of ligation-
mediated PCR-aided in vivo footprinting and genomic sequencing. This 
improvement in the quality of in vivo footprint data allows the pattern of 
protei~:DNA interactions to be obtained with greater signal to noise and for a 
larger group of DNA sequences. The fourth chapter of this thesis uses these in 
vivo footprinting techniques to investigate the mechanisms controlling the 
transcription of the mouse interleukin-2 gene upon T cell stimulation. T cell 
stimulation was shown to result in the coordinated occupancy of a number of 
major groove binding proteins to the previously unoccupied IL-2 regulatory 
region in vivo. Finally, the appendix describes in vivo footprints at the 
differentiated-muscle-specific promoter of the delta-subunit of the nicotinic 
acetylcholine receptor. Multiple protein:DNA interactions were seen at the 
promoter both before and after muscle cell differentiation, suggesting that 
transcriptional regulation of this gene occurs at the level of protein 
replacement or an alteration of the ability of the assembled proteins to activate 
transcription. 
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Cellular transcription results in the copying of one strand of the DNA 
duplex into RNA. The process of transcriptional control determines which 
portions of the genomic DNA a cell expresses in the form of RNA and the 
rate at which each RNA species is made. Transcriptional control plays a very 
important role in the development and function of an organism. Its 
importance can be seen in the drastic, and often lethal, developmental 
perturbations caused by the deletion or misexpression of individual 
transcriptional control factors (Davidson 1991). An enormous amount of 
information has been obtained on the subject of transcriptional control. In 
this relatively short review I will try to summarize many of the key concepts 
and present specific examples to illustrate particular points. My major focus 
will be on the mechanisms of transcriptional control in mammals. However, 
many basic structural and functional similarities among transcriptional 
control mechanisms have been demonstrated for a number of different 
eukaryotes (Guarente and Bermingham-McDonogh 1992). Thus, I have 
incorporated specific examples from eukaryotes other than mammals, such as 
the fruit fly Drosophila melanogaster and the budding yeast Saccharomyces 
cerevisiae, in cases where these can serve to illustrate a certain principle 
particularly clearly. 
Transcriptional control of protein-coding genes in eukaryotes is 
mediated through DNA sequences that flank, and occasionally include, the 
coding region. These gene-specific cis-acting DNA sequence elements 
interact with sequence-specific DNA-binding proteins, which in turn, directly 
or indirectly, control the assembly and activity of the general RNA 
polymerase II machinery of the cell at the core promoter near the 
transcriptional start site. Each step along this pathway can be a locus for 
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transcriptional control. The occupancy of a regulatory region by regulatory 
proteins involves multiple interactions among sequence-specific DNA-
binding proteins, cis-acting DNA sequence elements and the chromatin into 
which the DNA sequence elements are packaged. Each of these components, 
such as the set of DNA-binding proteins available or the status of the 
chromatin are targets for control by the cell. The subsequent transcriptional 
control effects of these gene-specific, DNA-bound regulatory proteins on the 
general RNA polymerase II machinery reflects both the intrinsic qualities of 
the bound proteins, the availability of both gene-specific and general non-
DNA-binding regulatory proteins with which the DNA-bound proteins can 
interact, and the modifications that have been made to all the proteins 
involved. Each of the components involved in the activation and repression 
of the general RNA polymerase II machinery are also targets for control by 
the cell. Finally, even after transcription has been initiated, the elongation 
properties of RNA polymerase II can also be a target for control. Thus 
transcription involves the multistep assembly of a large, multiprotein 
complex (whose molecular weight greatly exceeds one million kD) on a DNA 
template. The complexity and diversity of the components of this molecular 
machine provide multiple opportunities for fine-tuned control of 
transcription. 
This discussion of transcriptional control will begin with a description 
of the structure and function of key components involved in the conversion of 
DNA-binding by gene-specific regulatory factors to control of RNA 
polymerase II activity. Transcriptional control domains of gene-specific 
regulators, the basic RNA polymerase II machinery of the cell, and the 
proteins that may serve as intermediates between the two will be described, 
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as well as how the gene-specific regulators control the general machinery. 
The second section of the review discusses how the transcriptional regulatory 
activity of the gene-specific regulators is controlled by the cell. In the third 
section, the mechanisms controlling the occupancy and activity of an entire 
regulatory region will be discussed, focusing on how the regulatory region 
integrates multiple regulatory inputs into a single transcriptional output. The 
final section discusses major experimental approaches to transcription. 
I) TRANSCRIPTIONAL ACTIVATION VIA BOUND REGULA TORY 
FACTORS: 
Gene-specific regulatory factors: 
Sequence-specific DNA-binding proteins exert their effects on 
transcription through both DNA:protein and protein:protein interactions. 
Often the DNA:protein interaction is necessary but not sufficient for a factor 
to regulate transcription. In these cases the DNA:protein interaction is 
required mainly to bring to the DNA regulatory region of interest additional 
protein domains that control transcription through protein:protein 
interactions. For example, SPl, a DNA-binding regulator that stimulates 
transcription, contains a set of zinc-fingers which interact with DNA. 
However, DNA-binding of this domain alone exerts no control of 
transcription. Separate non-DNA-binding regions of the protein, including 
two glutamine-rich domains, are required for SPl to stimulate transcription 
(Courey and Tjian 1988). Such separate transcriptional regulatory domains 
have been found for most DNA-binding transcriptional regulators. Several 
different classes of transcriptional control domains which stimulate 
transcription have been identified, including the glutamine-rich domains of 
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SP1 and Oct 2, the proline-rich domains of CTF and AP2, and the acidic 
domains of GAL4 (Gill and Tjian 1992). This suggests that not only do most 
DNA-binding transcriptional regulatory proteins regulate transcription 
through protein:protein interactions, there may be several distinct classes of 
proteins that serve as targets of these domains and that each class of 
regulatory domain may talk to a specific type of target. 
Gene-specific transcriptional regulatory proteins need not have the 
ability to bind DNA on their own. They can associate with a DNA regulatory 
region through protein:protein interactions with factors that do possess 
DNA-binding ability. The transcriptional activator VP16, for example, 
activates transcription of the herpes virus infected cell protein 4 promoter 
(ICP4) by associating with DNA-bound Oct-1 (recent evidence indicates VP16 
can weakly recognize some DNA sites, though it need not do so to activate 
transcription; Thompson and McKnight 1992). It is important to note that 
these non-DNA-binding regulatory proteins continue to function when fused 
to DNA-binding proteins and their transcriptional regulatory domains fall 
into the same classes as those of the DNA-binding proteins. Thus they do not 
appear to regulate transcription through a distinct set of mechanisms. 
The proteins discussed so far have all been transcriptional activators. 
Regulators which function as transcriptional repressors are also common and 
they can be either DNA-binding or non-DNA-binding proteins (Johnson and 
Krasnow 1992; Keleher et al. 1992). Repressors can function either through 
competition for an activator's DNA-binding site, competition for the general 
RNA polymerase machinery's DNA-binding site or through repressive. 
protein:protein interactions. Thus, both transcriptional activators and 
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repressors exert their effects through both protein:DNA and protein:protein 
interactions. 
Assembly of general transcriptional machinery at the core promoter 
Core promoters usually contain the TATA and/or initiator (Inr) 
sequence elements and interact with components of the basic transcriptional 
machinery of the cell. These sequence elements alone or together are 
sufficient to drive a basal level of accurately initiated transcription in vitro 
(Roeder 1991). However, a core promoter is insufficient to drive appreciable 
levels of transcription in the living cell, relying on gene-specific activators to 
function in vivo. Nonetheless, its serves the same basic function in vitro as in 
vivo, bringing RNA polymerase II to the promoter, and hence its function has 
been productively studied in vitro. 
The general transcription machinery assembles on the core promoter 
through a precise pathway of interactions (Buratowski et al. 1989; Roeder 
1991). The first step is binding of the TATA-binding transcription factor 
TFIID with the TATA element. TFIIA assists in the assembly of this complex, 
binding cooperatively with TFIID, though it has no intrinsic sequence-
specific-DNA-binding ability on its own. TFIIB binds this complex, 
assembling across the initiation site though it too has no intrinsic sequence-
specific-DNA-binding ability. This TFIIA+TFIID+TFIIB complex recognizes 
and binds to RNA polymerase associated with TFIIF (which suppresses RNA 
polymerase's intrinsic affinity for non-specific DNA, which might otherwise 
cause it to bind non-promoter DNA; Greenblatt 1991). Then TFIIE binds, 
completing formation of the transcriptional pre-initiation complex (preiC). 
Addition of nucleotide triphosphates to the preiC results in transcriptional 
initiation within seconds (Kadonaga 1990). 
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Genes that do not contain TATA elements, but that do contain initiator 
(Inr) elements utilize the Inr binding factor TFII-1, which recognizes the 
degenerate consensus sequence YAYTCYYY (Roy et al. 1991). TFII-1 interacts 
with TFIID to bring it to 1m-containing core promoters, and on promoters 
containing both TATA and Im elements, it can compensate for the removal of 
TFIIA activity from an in vitro transcription reaction (Roy et al. 1991). 
Whether the TFII-1 and TFIIA normally collaborate on promoters containing 
both has not yet been resolved. Subsequent steps in the TFII-1 mediated 
pathway appear to utilize the same factors as the TFIIA-mediated pathway 
(Roy et al. 1991; Zenzie-Gregory et al. 1992). Some promoters contain neither 
obvious Im nor TATA elements. The precise mechanism of transcription 
complex assembly at these promoters is unclear, but those examined can 
function using the same crude transcription extracts as 1m-containing and 
TATA-containing promoters (O'Shea-Greenfield and Smale 1992; Zenzie-
Gregory et al. 1992). Thus there is diversity in the structure of core 
promoters, but most appear to utilize similar sets of general transcription 
factors. The recent discovery that the core promoters of RNA polymerase I 
and RNA polymerase III genes can also utilize components of TFIID (see 
below) in transcriptional activation indicates that all transcription may utilize 
at least some of the same general factors (White and Jackson 1992). 
Role of core promoter in determining transcriptional start site and direction 
Core promoters also control the selection of start site and direction of 
transcription, as most elements that interact with gene-specific activators and 
repressors can function in either orientation upstream or downstream of the 
initiation site. Both the TATA and Inr elements can specify the 
transcriptional initiation site and the direction of transcription in vitro. In 
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mammals, the TATA element has been shown to specify initiation at a 
discrete site approximately 25 bp downstream on one strand, while the 
initiator specifies unidirectional initiation within its site . When the TATA 
and Inr elements are separated by more than 30 bp, transcription initiates 
approximately 25 bp downstream of the TATA element (O'Shea-Greenfield 
and Smale 1992). This indicates that the TATA element plays a more 
powerful role in start site selection than the lnr. Similarly, the orientation of 
the TATA element determined the direction of transcription when the TATA 
and Inr were of opposite orientation (O'Shea-Greenfield and Smale 1992). 
However, examination of the Adenovirus IVa2 (Ad 1Va2) promoter shows 
these generalizations are not absolute (Carcamo et al. 1990). The Ad 1Va2 
promoter contains a functional TATA element in a reversed orientation 
between 14 and 21 base pairs downstream of the transcriptional start site. 
Transcription initiates w ithin the Ad 1Va2 promoter's Inr element, and the Inr 
appears to control both the start site and the directionality of transcription. 
Though no further evidence is available for this promoter, this exception may 
be caused by the relative positions of Inr, TATA and the relatively 
uncharacterized NTF-factor binding site located just upstream of the Inr. In a 
test promoter, several SP1 sites were located 25 bp downstream of a TATA 
element. This caused the TATA element to facilitate transcriptional initiation 
approximately 25 bp away from the TATA element, but heading away from 
the SP1 sites (O'Shea-Greenfield and Smale 1992). Thus the presence of 
multiple SP1 sites just downstream of the TATA caused a reversal of 
transcriptional direction and transcriptional start site position. Although this 
shows that there can be complex interactions between core elements and 
gene-specific activators in some cases, in general the core elements play the 
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major role in determining the choice of start site and directionality of 
transcription. 
As noted above, some promoters contain no obvious TATA or Inr 
elements. These promoters fall into two groups: those that initiate 
transcription at a discrete start site and those that initiate at multiple start 
sites over a region that can extend to over a hundred base pairs, often 
bidirectionally. Many of the former contain elements which show little 
homology to lnr sequences or each other, but function like an Inr in vitro 
(O'Shea-Greenfield and Smale 1992). One such non-lnr initiator is present in 
the mouse dihydrofolate reductase gene (Means and Farnham 1990). This 
sequence element interacts with a sequence-specific DNA-binding protein 
named HIP1 (Means and Farnham 1990). It is possible that HIP1 and TFII-1 
may be related activities. Although the lnr sequence recognized by TFIT-1 is 
unrelated to the HIP1 recognition sequence, such an interaction is not 
unprecedented, as TFII-1 can bind with high affinity to other lnr-unrelated 
sequences (Roy et al. 1991). Thus the biochemical properties of the non-Inr 
initiator core promoters are not well understood, but are potentially similar to 
the lnr mechanism. Finally, even less well understood are the TAT A-less, Inr-
less promoters which direct transcription from heterogeneous start sites 
(Zenzie-Gregory et al. 1992). Such a promoter supports heterogeneously 
initiated, bi-directional RNA polymerase II transcription in vitro, but the 
mechanism is unknown (Zenzie-Gregory et al. 1992). 
Coactivators facilitate protein:protein interactions between gene-
specific regulatory factors and the general machinery at the core promoter. 
To work out the molecular mechanisms by which gene-specific 
transcriptional activators and repressors function, the effect of these factors 
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on the general transcriptional machinery have been tested using in vitro 
transcription systems. An important clue to the way in which gene-specific 
activators work came with the isolation from several species of the gene 
encoding the TATA-binding component of TFIID, or the TATA-binding 
protein (TBP) (Ptashne and Gann 1990). When added to an in vitro 
transcription reaction depleted of TFITD, bacterially produced TBP supported 
the same level of basal transcription as native TFIID purified 
chromatographically from mammalian or Drosophila cells. But when gene-
specific transcriptional activator proteins were added to the in vitro 
transcription mixture, reactions containing native TFITD showed increased 
levels of in vitro transcription, whereas those containing recombinant TBP did 
not. Subsequent experiments showed that native TFITD is a multiprotein 
complex containing, in addition to TBP, a number of other proteins called 
TBP-associated factors (TAF's) (Dynlacht et al. 1991) (Tanese et al. 1991). 
Separating TFITD's components with urea yielded a fraction with TBP activity 
that could support basal transcription and a fraction that alone supported no 
transcription but when combined with the other fraction reconstituted the 
ability of activators to stimulate transcription (Dynlacht et al. 1991). At least 
some of the TAF's are believed to mediate the effect of gene-specific activators 
on the general transcriptional apparatus of the cell and thus to serve as 
"coactivators." In addition to the TAF's, there may be other proteins that can 
function to mediate the effects of gene-specific activators, but which are not 
physically associated with components of the basal transcriptional apparatus 
prior to its assembly on a core promoter (Meisterernst et al. 1991). Although 
activators apparently require coactivators to function, some activators, such 
as VP16, can physically associate with the basal transcriptional machinery in 
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the absence of coactivators. For example, VP16 binds to TBP and to TFIIB in 
vitro (Stringer et al. 1990; Lin and Green 1991). These direct interactions could 
be functionally significant, as mutations that disrupted VP16's interactions 
with general factors decreased its activating potential (Lin et al. 1991; Ingles et 
al. 1991). Thus gene-specific activators (and possibly repressors) can alter the 
activity of the general transcription apparatus required for basal transcription 
(TBP, TFIIA, TFIIB, etc .. ) by working in concert with or through coactivators 
which are not required for basal transcription. 
Gene-specific activators can work by antagonizing the repressive effects of 
chromatin on core promoter function. 
The assembly of a transcriptional initiation complex is a complex, 
multistep process, and each step along this pathway constitutes a potential 
target of gene-specific activators and repressors. As noted above, a core 
promoter is sufficient to promote a basal level of transcriptional initiation in 
vitro, but additional elements that interact with gene-specific factors are 
required for transcription in vivo. An important experimental detail is that 
the in vitro transcription reactions used to study basal level transcription 
above used DNA templates that were free of protein, also known as naked 
DNA, as starting material. However, DNA in the cell is associated with 
chromosomal proteins, such as histones, which package the cellular DNA and 
can exert a powerful repressive effect on transcription in vivo (Felsenfeld 
1992). A major component of chromatin is the histone octamer which is 
formed by two of each of the four core histones (H2A, H2B, H3, H4). The 
histone octamer interacts with approximately 146 bp of DNA, which is 
wound around the octamer core, creating a nucleosome. Histone H1 
recognizes nucleosomes and can bind the DNA between adjacent 
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nucleosomes, serving to package the nucleosomal "beads on a string" more 
compactly (Hayes and Wolffe 1992). Thus, chromatin structure is known to 
have a powerful effect on transcription in vivo and enough components of 
chromatin are known to attempt to study its effect on transcription in vitro. 
Packaging DNA templates into nucleosomes (using the purified core 
histones H2A, H2B, H3, and H4) prior to use in an in vitro transcription assay 
mildly repressed basal level transcription two to four fold (Laybourn and 
Kadonaga 1991). The addition of histone H1 to the nucleosomes resulted in a 
further ten to twenty-fold repression of basal level transcription (Laybourn 
and Kadonaga 1991). Repression by the core histones was caused by the 
formation of a nucleosome on the core promoter, and the H1-mediated 
increase in repression was postulated to involve the binding of H1 to the 
fraction of core promoters that were located between nucleosomes (Laybourn 
and Kadonaga 1991). That chromatin can inhibit transcription by blocking 
the access of general factors to the core promoter is consistent with the 
previous finding that binding of TFIID to the core promoter prior to 
packaging the template into chromatin prevented repression (Workman and 
Roeder 1987). 
When chromatin assembly using H1 and the core histones took place 
in the presence of a sequence-specific activator such as GAL4-VP16, the level 
of in vitro transcription subsequently observed was 200-fold higher than in 
the absence of GAL4-VP16 (Laybourn and Kadonaga 1991). This 200-fold 
activation of transcription is much closer to the large in vivo effects seen with 
GAL4-VP16 than the eight-fold activation seen in the absence of histones 
(Laybourn and Kadonaga 1991). Thus GAL4-VP16 appears to activate 
transcription both through counteracting the repressive effects of histone H1-
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containing chromatin (an activity termed antirepression) and by stimulating 
the activity of the general transcriptional machinery using naked DNA 
templates. Similar experiments using the GAL4-VP16 protein showed that 
both the DNA-binding and transcriptional activation domains were required 
for antirepression (Workman et al. 1991). This argues that in addition to 
DNA-binding, protein:protein interactions between gene-specific activators 
and the general transcription apparatus and/or between activators and 
chromatin components play important roles in antirepression. Thus a key 
component of activator function is to counteract the repressive effects of 
chromatin on the basic transcriptional apparatus by antirepression. 
Repressors could work by promoting or stabilizing a repressive chromatin 
structure. 
The activation of a silent gene often involves the remodeling of 
chromatin structure (Felsenfeld 1992). However, in the above experiments 
gene-specific factors such as GAL4-VP16 (and SP1) could not reverse the 
repressive effects of chromatin if they were added after chromatin assembly. 
This could reflect a limitation particular to the gene-specific factors examined; 
perhaps GAL4-VP16 and SP1 serve only to keep already activated genes 
open. Or, it could suggest that these factors do not act alone in counteracting 
repressed chromatin structure. For example, the assay used in the above 
experiments might be missing factors which assist gene-specific regulatory 
proteins in accessing nucleosomal DNA in vivo, such as the SNF /SWI 
products discussed below, which have been implicated in the regulation of 
chromatin structure (Winston and Carlson 1992). 
Gene-specific activators and repressors can affect the rate and extent of 
active pre-initiation complex assembly 
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Gene-specific activators can work not only by altering the effects of 
chromatin on the general transcription apparatus (antirepression), but also by 
changing the nature of particular steps in transcriptional pre-initiation 
complex (preiC) assembly. Transcriptional regulators could change the rate 
of preiC formation or alter the equilibrium constant of formation such that a 
different percentage of accessible templates form active preiC's. A regulator 
could also alter the rate at which a preiC initiates transcription or the rate at 
which the next preiC can form after a round of transcriptional initiation. 
Though their precise targets in the general transcriptional apparatus are still 
unclear, measurements of the percentage of templates on which preiC 
complexes form over time indicate that different regulators can have different 
effects on preiC formation. The transcriptional activator TGA1a increases 
both the rate and extent of preiC formation in vitro (Katagiri et al. 1990), 
whereas GAL4-VP16 increases the number of preiC's formed without 
changing the rate at which they form (White et al. 1992). Thus, gene-specific 
activators can affect either the rate and/or extent of preiC formation in vitro . 
An important recent insight is that transcriptional initiation can be 
controlled not only by the number of complexes formed at the core promoter, 
but by the balance between formation of active (preiC's) versus inactive 
complexes. The Roeder laboratory has found that more than one type of 
TFIID containing complex can form on the core promoter. Several activities, 
including NC1 and NC2, were identified which can compete with TFIIA for 
assembly with TFIID and res1.11t in the formation of TFIID-NC1 or TFIID-NC2 
complexes on the core promoter (Meisterernst and Roeder 1991; Meisterernst 
et al. 1991). The TFIID-NC2 complex does not associate with TFIIB and the 
TFIID-NC2 complex as well as the TFIID-NCl complex are transcriptionally 
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inert. A potential function of gene-specific regulators could be determining 
the balance between these different complexes. 
In vitro studies of the gene-specific activator UBX and the gene-specific 
repressor EVE are consistent with these regulators exerting opposite effects 
by altering the balance of active versus inactive complex formation (Johnson 
and Krasnow 1992). These Drosophila regulatory proteins do not alter the rate 
of preiC formation. Instead, they alter the number of preiC's formed. 
Furthermore, once preiC assembly is complete, neither protein exerts a 
regulatory effect, suggesting that the production of active versus inactive 
complexes can be influenced during their formation, but not after they have 
formed. After addition of nucleotide triphosphates the regulatory proteins 
can again exert an effect. Thus, a first step in transcription complex assembly 
can be seen to involve an initial partitioning of core promoters into active 
versus inactive complexes, in a process subject to the influences of gene-
specific regulators. After this initial complex formation, in a step not 
influenced by either of the regulators examined here, transcription is initiated 
from the active complex or the inactive complex disassembles in an ATP-
dependent step. Then the process of competition between active and inactive 
complexes starts again (Roeder 1991; Johnson and Krasnow 1992). It will now 
be important to directly observe the constituents of the active and inactive 
complexes formed to see if they include TFIIA and NC1/NC2 respectively. 
Though the EVE repressor has been shown to alter preiC assembly in 
vitro, gene-specific repressors could also act via other, less direct mechanisms. 
A repressor could compete with an activator for a DNA-binding site (Keller 
and Maniatis 1991; Hoch et al. 1992), or mask an activator's transcriptional 
activation domain (Leuther and Johnston 1992), hence repressing 
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transcription by depriving the core promoter of an essential activator. 
Alternatively, a repressor could act by binding to the core promoter and 
preventing the binding of 1FIID (Stromstedt et al. 1992). In a similar vein, an 
apparent gene-specific activator could also function by antagonizing the 
function of any of these types of repressors. 
Gene-specific regulators can also alter steps after transcriptional initiation 
After the preiC forms, the RNA polymerase can begin synthesizing 
RNA. However, this elongation step is also a target for regulatory proteins. 
In the case of the human immunodeficiency virus type-1 (HIV-1) promoter, 
most of the elongating RNA polymerases pause just downstream of the 
promoter and transcription terminates 60 to 80 nucleotides after initiation. In 
the presence of the viral regulator Tat, which interacts with the first 79 
nucleotides of the nascent transcript, transcriptional elongation proceeds 
(Karn and Graeble 1992). Thus, Tat activates production of HIV-1 RNA by 
acting after transcriptional initiation. The observation that polymerases can 
stall just downstream of initiation is not restricted to viral promoters, as many 
Drosophila promoters contain RNA polymerases paused within 25 bases of 
the start site, as determined by a combination of in vivo crosslinking, nuclear 
transcriptional run-on, and in vivo detection of melted DNA experiments 
(Rougvie and Lis 1990; Giardina et al. 1992). The regulatory role of RNA 
polymerase pausing in these promoters is unclear, as heat shock promoters 
show equivalent numbers of paused polymerases before and after induction 
of heat shock RNA synthesis (Giardina et al. 1992). Furthermore, it does not 
appear that RNA polymerase pausing exerts a simple negative effect on 
transcription, as mutation of the pause sites in the HIV-1 (Karn and Graeble 
1992) and hsp70 (Lee et al. 1992) promoters decreases the production of 
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transcripts from these genes upon induction. In an attempt to reconcile the 
apparent negative and positive effects of polymerase pausing, Giardini et al., 
(1992) have postulated that the presence of the paused polymerase complex 
may assist in the initiation of the next transcript. In this model, the pause site 
would decrease the basal level of expression by preventing efficient 
elongation, perhaps through interaction with a repressor of elongation. 
Positively acting factors would then increase the rate at which the polymerase 
leaves the pause site without eliminating the pause. If the paused 
polymerase complex assisted in assembly of the next transcription complex, 
then the positively acting factors would eliminate the repression of 
elongation, but leave the activating capacity of the paused polymerase 
complex intact. Thus paused polymerases could exert both a positive effect 
on transcriptional initiation and a negative effect on elongation, with the net 
effect determined by the balance between the two. There is as yet no 
mechanistic evidence for this model. Nonetheless, the existence of 
polymerase pausing and the ability of regulators to work at the level of 
elongation have been established. 
The effect of gene-specific regulators on the choice of RNA start site 
As noted above, in certain cases gene-specific regulators can affect the 
choice of start site and direction of transcription. The role of gene-specific 
regulators in the choice of start site in vivo was established for the HIS3 
promoter in yeast, in which constitutive and inducible regulatory elements 
directed transcription through alternate TATA boxes (Struhl, 1986). As 
discussed previously, core promoters that function through TATA and/or 
initiator elements initiate transcription at relatively discrete start sites, 
whereas many promoters lacking TATA and initiator elements initiate 
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transcription at dispersed sites. As described in Garrity and Wold (1990), we 
found that the choice of core promoter in the mouse metallothionein-I (MT-I) 
gene was not restricted to decisions between alternate TATA boxes, but could 
involve using TAT A-dependent versus TAT A-independent mechanisms. The 
choice of core promoter showed tissue-specificity, as TATA-independent 
transcripts predominated only in the meiotic germ cells of the testis. This 
could be due to tissue-specific regulatory factors. However, a plausible 
alternative explanation would be that this effect reflects testis-specific 
changes in the basic transcriptional machinery, a hypothesis supported by the 
' subsequent observation of TAT A-independent start site usage in testis by the 
herpes simplex virus type-1 thymidine kinase promoter (Al-Shawi et al. 
1991). In addition to showing different tissue-preference, the two modes of 
MT-I transcription also differed in their environmental responsiveness 
(Garrity and Wold 1990). The production of the TAT A-dependent transcripts 
could be stimulated through the MT-1 metal responsive enhancer elements, 
while the TATA-independent transcripts could not be. In addition, site-
directed mutation of the TATA-element created a largely metal-insensitive 
MT-1 regulatory region. This differential ability of the TAT A-dependent and 
TATA-independent start sites to be activated through the metal responsive 
enhancer elements could be due either to the relative positions of the different 
start sites and the metal responsive enhancer elements or to an inability of the 
metal responsive enhancer elements to stimulate TAT A-independent 
transcription. The recent isolation of many of the key factors involved in the 
function of the TATA and initiator elements provide some of the tools for 
approaching the mechanism behind these observations. 
II) CELLULAR CONTROL OF GENE-SPECIFIC REGULATORS 
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In the first section, I discussed the mechanisms by which individual 
gene-specific regulators exert their effects on the basic transcriptional 
machinery of the cell. Having established that transcriptional regulation 
works through these gene-specific regulators, it is important to understand 
how the cell modulates the activity of the transcriptional regulators as these 
regulators are its means of creating a developmentally and environmentally 
responsive pattern of gene expression. As the final pattern of gene expression 
must take into account a diverse combination of developmental and 
environmental information, control points where diverse information is 
integrated are especially important to understand. 
Several distinct properties of transcriptional regulators are subject to 
control. Is a regulator to act as an activator or a repressor of transcription, or 
neither? · The same protein bound to a DNA regulatory region could 
potentially be used to exert multiple effects. Can the regulator bind to DNA, 
and if so what is its sequence-specificity? By exerting control over these 
aspects of a regulator's behavior, the occupancy of particular regulatory 
sequence elements can be influenced by signals that the cell receives. Finally, 
for non-DNA binding regulators, with what DNA-binding factors can they 
associate? Control at this level can be used to control the recruitment of these 
non-DNA regulators to promoter regions. Though these properties can be 
controlled in a number of ways, two general strategies can be defined. The 
first is the use of covalent or non-covalent modification of individual factors . 
The second is the use of interactions between individual factors. In many 
cases, both strategies are used simultaneously. For example, covalent 
modification of individual factors is often used to control interactions 
between factors . However, for didactic purposes I will discuss the two 
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separately (focusing on phosphorylation as an exemplary modification of an 
individual factor), and present particular examples that point out important 
regulatory implications. 
Control by phosphorylation 
Phosphorylation, like other covalent and non-covalent (e.g., ligand-
binding) modifications, can change a protein's function by altering its 
conformation (perhaps exposing an important domain) or by specifically 
changing the properties of an active surface (such as a nucleotide binding site 
or a DNA-binding motif). Of the many examples of phosphorylation control 
of regulatory factors, two of particular interest concern factors potentially 
involved in the regulation of the interleukin-2 (IL-2) promoter, which is the 
subject of Chapter 3 of this thesis. The first factor is NF-KB, whose role in IL-2 
transcription is complicated by the presence in activated T cells of a number 
of apparently distinct factors with related DNA-binding activities (Briegel et 
al. 1991; Lee et al. 1991; Urban et al. 1991). The second factor is NF-AT, whose 
combined pattern ofT-cell restricted expression, DNA-binding-selectivity, 
and immunosuppressant drug sensitivity (see below) appear unique and 
correlate well with the pattern of IL-2 transcription, strongly suggesting that 
it is a regulator of IL-2 transcription. 
The major species of the DNA-binding transcription factor NF-KB is a 
hetero-oligomer of two members of the c-rel gene family (Fujita et al. 1992; 
Nolan and Baltimore 1992). Though it is reliant on phosphorylation for 
activity in many cell types, it is probably only an indirect target of the major 
phosphorylation event. In these cells, NF-KB is present in the cytoplasm in a 
complex with members of the I-KB protein family (Baeuerle and Baltimore 
1988). This cytoplasmic complex lacks DNA-binding ability in vitro, as well 
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as being in the wrong compartment of the cell to activate transcription of 
nuclear genes in vivo. Treatment of the HeLa cell line or the pre-B cell line 
70Z/3 with stimuli such as the phorbol ester TP A, which can activate protein 
kinase C (PKC), causes the NF-KB/1-KB complex to dissociate. The freed NF-
KB relocalizes to the nucleus and can now recognize DNA (Baeuerle and 
Baltimore 1988). This chain of events has been investigated in vitro, where 
PKC was shown to phosphorylate the 1-KB component of the NF-KB/1-KB 
complex, resulting in the dissociation of the complex and the activation of 
NF-KB DNA-binding activity (Ghosh and Baltimore 1990). Thus 
phosphorylation of 1-KB by PKC can activate NF-KB in vitro, but it has not yet 
been shown that stimuli such as TPA activate NF-KB through 
phosphorylation of 1-KB in vivo. Although the ankyrin repeats in the 1-KB 
family members are involved in this interaction, the molecular details of the 
interaction and how it is regulated by phosphorylation are unknown (Nolan 
and Baltimore 1992). Finally, the mechanism by which 1-KB sequesters NF-KB 
in the cytoplasm is also unknown. 1-KB could act as a cytoplasmic anchor or 
it could mask the nuclear transport signal on NF-KB (Hunter and Karin 1992). 
In summary, in vitro studies using purified components have shown a 
mechanism by which NF-KB can be activated. It appears likely that 
phosphorylation will also play a role in its activation in at least some 
situations in vivo, though the precise mechanisms used may be different. 
The nuclear factor of activated T cells (NF-AT) is a second regulatory 
factor involved in IL-2 transcription whose activity is controlled by 
phosphorylation. NF-AT is a multi-component T-cell-specific, DNA-binding 
factor. It is produced in a protein-synthesis-dependent fashion within 20 
minutes after stimulation ofT-cells with the combination of TPA and a 
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calcium ionophore, which together mimic many of the effects of T-cell 
activation through antigen recognition, including stimulation of IL-2 
transcription (Shaw et al. 1988; Crabtree 1989). Through a series of in vitro 
DNA-binding assays using nuclear and cytoplasmic extracts from stimulated 
and unstimulated cells, NF-AT was found to consist of at least two parts 
(Flanagan et al. 1991). One is aT cell restricted factor which is present in the 
cytoplasm of unstimulated cells, but is translocated to the nucleus upon 
treatment of the cells with TP A and ionophore or with ionophore alone 
(Flanagan et al. 1991). The other is a factor, containing c-fos and c-jun Gain et 
al. 1992), that is synthesized in a number of different cell types in response to 
treatment with TPA or TPA+ionophore and which is located in the nucleus of 
the activated cell (Flanagan et al. 1991). Stimulation ofT cells with TP A and 
ionophore in the presence of the immunosuppressant drugs cyclosporin A 
(CsA) or FK506 does not result in the synthesis of a number of the 
lymphokines that are normally produced by activated T cells. Among the 
many effects of CsA and FK506, transcriptional activation of IL-2 is blocked 
as well as the production of NF-AT (Mattila et al. 1990). When the presence 
of NF-AT components in different cellular fractions were examined after 
stimulation in the presence of CsA or FK506, the presence of the TP A-
responsive nuclear component was unaltered, but the cytoplasmic 
component had not translocated to the nucleus (Flanagan et al. 1991). Thus 
these drugs appear to inhibit NF-AT production by blocking a calcium 
ionophore-responsive translocation event. 
CsA and FK506 are known to function through their interactions with 
cellular proteins called immunophilins, CsA interacting with the cyclophilin 
family and FK506 interacting with FK506-binding protein (FKBP) family 
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(Schreiber and Crabtree 1992). Though the cyclophilins are not homologous 
to the FKBP's, both families encode proteins with cis-trans prolyl isomerase 
activity, and thus have the potential to be involved in protein folding. 
Though both CsA and FKBP inhibit the prolyl isomerase activity of their 
respective immunophilin targets, this is not thought to be the mechanism by 
which they exert their immunosuppressant effects, as molecules related to 
FK506 inhibit this activity just as efficiently but do not have 
immunosuppressive effects (Schreiber and Crabtree 1992). Instead, CsA and 
FK506 each function, at least in part, as a component of a 
drug/immunophilin complex which has been demonstrated to bind and 
inhibit the activity of the calcium- and calmodulin-dependent protein 
phosphatase calcineurin in vitro (Liu et al. 1991). The in vivo validity of this in 
vitro model was assessed by overexpressing native calcineurin or a 
constitutively active form of calcineurin in a human T cell line (Clipstone and 
Crabtree 1992; O'Keefe et al. 1992). This overexpression increased the 
concentrations of CsA and FK506 required to inhibit transcription from the 
IL-2 promoter as well as to inhibit transcription from a reporter plasmid 
regulated by several NF-AT recognition sites. In addition, the overexpression 
of calcineurin decreased the need for calcium ionophore to stimulate 
transcription, whereas the overexpression of a different phosphatase had no 
effect. Thus, calcineurin can play an important role in T cell activation and 
CsA and FK506 exert at least some of their immunosuppressive effects by 
inhibiting its activity. Combining this data with the effects of these drugs on 
NF-AT synthesis and activity strongly suggests that the nuclear translocation 
of the T-cell-specific cytoplasmic component of NF-AT depends on a 
dephosphorylation event. Furthermore, the synthesis of the other component 
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of NF-AT is stimulated by TP A, suggesting that its production can be 
regulated by PKC. In both cases the precise targets of the phosphorylation 
and dephosphorylation events are unknown, however phosphorylation can 
control both the production and cellular localization of the components of 
NF-AT. 
In addition to altering the cellular localization of regulatory factors, 
phosphorylation can alter the ability . of proteins to bind to DNA and to 
regulate transcription. One example that illustrates both principles is the 
control of c-jun function (a component of AP-1) by phosphorylation. 
Phosphorylation of threonine and serine residues near its DNA-binding 
domain can inhibit c-jun's ability to bind DNA in vitro (Lin et al. 1992). 
Activation of PKC results in the dephosphorylation of these residues in vivo 
and an increase in AP-1 binding activity (Boyle et al. 1991). Phosphorylation 
can also alter the ability of c-jun to activate transcription when bound to 
DNA, as phosphorylation of serine residues in its activation domain (distinct 
from the serines near its DNA-binding domain) correlates with an increase in 
activation by AP-1 and mutation of these serines results in a decrease of 
transcriptional activating ability (Pulverer et al. 1991; Smeal et al. 1991; 
Hunter and Karin 1992; Smeal et al. 1992). In addition, phosphorylation not 
only can regulate whether or not a factor can bind DNA and what its 
transcriptional activation properties are, it can also regulate the sequence-
specificity of DNA-binding. The binding of the GHF1/Pitl factor to some 
sites was decreased by phosphorylation, while the binding to other sites was 
unaffected or enhanced (Kapiloff et al. 1991). Thus the cell can use 
phosphorylation not only to regulate whether or not a factor can bind DNA, 
it can affect to which site a factor binds as well. Though no examples were 
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specifically mentioned above, phosphorylation can also be used in the control 
of repressors of transcription (Hunter and Karin 1992). 
The effects of phosphorylation on DNA-binding and transcriptional 
activation vary depending on the regulators (both DNA-binding and non-
DNA-binding) being modified and the precise modifications that are made 
(Hunter and Karin 1992). In cases where increased phosphorylation inhibits 
DNA-binding or enhances transcriptional activation, the increased negative 
charge could function by electrostatically decreasing a DNA-binding 
domain's affinity for DNA or increasing an activation domain's acidic 
character. But these effects will apply to only a subset of such cases. Many of 
the regulatory effects of phosphorylation will result from conformational 
changes that expose or occlude DNA-binding surfaces, activation/repression 
domains, or regions of the protein involved in other sorts of protein:protein 
interactions. Changes in the chemical properties of surfaces of the protein 
that recognize other proteins, creating or destroying adhesive interactions, for 
example, could also be involved. And, as demonstrated for NF-1CB regulation 
through phosphorylation of 1-KB, the effects can be indirect. Despite the 
many clear examples of such regulation, the physical details of how 
phosphorylation affects regulatory factor activity remain largely a matter of 
speculation in most cases. 
Control through changes in the phosphorylation state of proteins is a 
way of rapidly altering the activity of regulatory factors in response to a 
signal. The abundance of different kinases and phosphatases with different 
substrate specificities ensure that combinations of signals can be sent 
separately through this cellular messenger system. NF-AT synthesis provides 
an example how this system can be used to integrate information. The signal 
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that stimulates translocation of the cytoplasmic component is different than 
the signal that stimulates production of the fos/jun containing component. 
Only the temporally coincident transmission of these two signals will result 
in the creation of the single transcriptional activator NF-AT. Systems such as 
this which allow for the integration of information are extremely important in 
the regulation of transcription. 
Oligomerization of regulatory factors 
Many transcriptional regulators contain domains that mediate 
protein:protein interactions and readily form oligomers with specific sets of 
partners (which often include themselves). Often these proteins function, for 
example, bind to DNA, only when oligomerized. Many of the regulatory 
proteins which possess the ability to oligomerize are members of large gene 
families, such as the helix-loop-helix (HLH), leucine zipper and NF-kB/ c-rel 
families (Murre et al. 1989; Lamb and McKnight 1991; Nolan and Baltimore 
1992). The members of individual families usually oligomerize with a limited 
subset of their own group, and some may oligomerize with apparently 
unrelated proteins (Bengal et al. 1992). This ability to create many different 
oligomeric species by combining a few different individual species in a 
number of different ways has been termed combinatorial complexity. Such 
combinatorial complexity can be used to create multiple species with distinct 
DNA-binding properties and transcriptional activation/repression 
properties. 
Combinatorial mechanisms not only increase the potential diversity of 
transcriptional regulators, they can be used to integrate multiple signals into 
a single output. Different proteins that can oligomerize with one another can 
each be controlled by different signals. Thus the creation of a key oligomeric 
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combination might rely on a number of different signal components. One 
situation in which such a scheme has been proposed is skeletal muscle 
differentiation (Benezra et al. 1990). 
Undifferentiated skeletal muscle precursor cells called myoblasts 
express members of the skeletal muscle-specific MyoD family (hereafter 
referred to generically as MyoD) of HLH proteins (Mueller and Wold 1989; 
Bober et al. 1991). These proteins can form DNA-binding oligomers with 
themselves as well as DNA-binding oligomers with other partners, such as 
the more ubiquitously expressed E2A proteins (Lassar et al. 1991). These 
MyoD-containing DNA-binding species appear to regulate the transcription 
of a number of genes expressed in differentiated skeletal muscle cells, 
including muscle creatine kinase (MCK) (Weintraub et al. 1991). But despite 
the presence of both MyoD and E2A proteins in myoblasts, differentiation-
specific genes such as MCK are not expressed. A combination of in vivo and 
in vitro analysis suggested one possible reason that differention-specific genes 
are not expressed in myoblasts is that the MyoD /E2A oligomers that 
recognize the transcriptional regulatory regions of MCK fail to form in the 
myoblast (Benezra et al. 1990). A possible mechanism explaining these 
observations came with the discovery of a variant form of HLH protein called 
Id (Benezra et al. 1990). Id can oligomerize with MyoD and with E2A family 
members, but neither the MyoD/Id nor E2A/Id oligomers bind to DNA. The 
levels of Id RNA were found to decrease upon muscle differentiation in vitro 
and overexpression of the Id protein inhibited activation of transcription 
through the MCK regulatory region (Benezra et al. 1990). Benezra et al. used 
these pieces of information to create a model in which the expression of 
differentiated skeletal muscle-specific genes was dependent on the formation 
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of MyoD/E2A family oligomers. The cell was marked as a determined 
myoblast by its expression of the MyoD family. However, until the 
circumstances were appropriate for it to stop proliferating and differentiate, 
high levels of Id would be expressed. High levels of Id would promote the 
accumulation of MyoD /Id or E2A/Id oligomers and inhibit the production of 
MyoD /E2A family oligomers. The signal to differentiate would 
downregulate Id levels, allow the production of MyoD /E2A family oligomers 
and thus allow expression of differentiated skeletal-muscle-specific genes 
such as MCK. Though recent observations complicate this simple picture 
(Bengal et al. 1992), it clearly illustrates the concept of using combinatorial 
complexity to integrate multiple signals into a single output and emphasizes 
how the relative levels and not just the presence or absence of different 
interacting proteins can exert powerful regulatory effects. 
In the previous example the existence of a key DNA-binding 
heteromeric combination was assumed and the effects of combinatorial 
complexity were described in terms of creating functional versus non-
functional oligomers. Though this case is a useful starting point, it is 
important to consider how combinatorial complexity could contribute to 
important alterations in DNA-binding specificity. In the case of the leucine 
zipper family regulatory proteins fos, jun, and ATF, different DNA-binding 
specificities have been described for different dimeric pairs. Fos-jun dimers 
preferentially bind AP-1 sites over CRE sites while jun-ATF dimers prefer to 
bind to CRE sites over AP-1 sites (Lamb and McKnight 1991). One could 
imagine that in a situation in which levels of jun were limiting, the relative 
levels of fos and ATF could determine whether a promoter containing AP-1 
sites or a promoter containing CRE sites functioned. If fos and ATF were 
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responsive to different signals, the two might function as a molecular balance, 
measuring the intensity of two inputs and turning on only one gene in 
response. This strategy of exploiting changes in specificity to create 
differential gene expression could also be utilized for combinations with 
differential transcriptional activation or repression effects or by DNA-binding 
pair-specific interactions with non-DNA-binding regulators. In summary, 
oligomeric interactions between proteins adds to the diversity of regulatory 
species available and can be used to help integrate information. 
Additional mechanisms that can control the activity of transcriptional 
regulators 
A number of other cellular mechanisms that can control the activity of 
transcriptional regulators have been identified. A number of these can 
considered covalent/non-covalent modification of regulatory factors, 
including ligand binding (Evans 1988) and proteolysis (Nolan and Baltimore 
1992). In addition to modification of the regulators, there can be modification 
of their DNA targets. Methylation of cytosine residues is the most common 
example of covalent modification of DNA and, as it is a heritable 
modification, it has been implicated in controlling such diverse heritable 
regulatory phenomena as X-chromosome inactivation and chromosomal 
imprinting (Riggs and Pfeiffer 1992). Methylation of a target binding site can 
limit interactions with regulatory factors in a selective fashion. For example 
methylation of a potential target site for both the myc/max and MLTF DNA-
binding regulatory factors inhibits the binding of myc/max, but not of MLTF 
to this site (Prendergast et al. 1991; Prendergast and Ziff 1991). Methylation 
can also exert a relatively non-specific repressive effect, mediated perhaps 
through repressor proteins that bind to methylated DNA such as CP-1 
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(Meehan et al. 1989). Thus the cell can exert regulatory influences through 
controlling both the activity of regulatory factors and, potentially, the 
templates upon which they assemble. 
III) PUTTING IT ALL TOGETHER: HOW A DNA REGULATORY 
REGION FUNCTIONS 
An essential property of a DNA regulatory region is that it has the capacity to 
integrate multiple inputs, diverse developmental and environmental 
information, into a single output, RNA transcript production. As described 
in the preceding sections it does so through interactions with DNA-binding 
factors that in turn, directly and indirectly, control the assembly and activity 
of the transcriptional machinery of the cell at the transcriptional start site. 
Some of the information it receives has already undergone integration, for 
example by using the oligomerization strategies mentioned above. However, 
much of the integrative process takes place right at the DNA regulatory 
region. The function of a DNA regulatory region can be separated into two 
parts: the occupancy of the DNA regulatory region by DNA-binding 
regulatory factors and the activation or repression of the basic transcriptional 
machinery by the bound regulators and their associates. Each part could 
conceivably function as an integrator of information. In the following section 
I discuss the mechanisms that may underlie these integrative functions. 
Regulatory region accessibility 
In order for gene-specific regulatory factors to recognize their DNA binding 
sites, the DNA in the site must be, to some extent, free from other 
interactions. DNA in the cell nucleus interacts with a variety of chromosomal 
proteins, such as histones, which can package and compact the DNA into 
structures, for example, the nucleosome described above. One effect of the 
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packaging of DNA into chromatin can be to inhibit the ability of gene-specific 
regulatory factors to gain access to their DNA binding sites. This inhibition 
could be through the masking of important chemical contacts or through 
steric hindrance (Hayes and Wolffe 1992). Regulation of the accessibility of 
the DNA regulatory region can be important in controlling regulatory region 
occupancy. 
Regulatory region accessibility plays an important role in controlling 
transcription of the mouse mammary tumor virus promoter. Prior to 
glucocorticoid treatment a nucleosome is present just upstream of the core 
promoter region and the promoter is inactive (Richard-Foy and Hager 1987; 
Archer et al. 1991). The addition of glucocorticoid stimulates the binding of 
glucocorticoid receptor (GR) to some of its recognition sites in the promoter, 
even though those sites are wrapped around the histone octamer. The 
binding of GR stimulates the disruption of the nucleosome (Richard-Foy and 
Hager 1987; Archer et al. 1991; Archer et al. 1992). Then other factors, such as 
the NF1 DNA-binding protein, which unlike GR could not bind to its target 
site until the nucleosome was disrupted, bind the exposed DNA regulatory 
region and transcription is stimulated (Cordingley et al. 1987; Archer et al. 
1992). Attempts to reconstitute this process in vitro have shown that although 
GR can bind its sites in nucleosomal DNA, it does not cause the disruption of 
the nucleosome seen in vivo nor does it facilitate the binding of NF1 (Archer 
et al. 1991). Thus the GR, through its. ability to recognize its target within 
nucleosomal DNA, facilitates the binding of additional gene-specific 
regulatory factors to the MMTV promoter. But though it is essential, 
additional factors are required to mediate this chromatin remodeling. 
Perhaps some these additional factors are related to the products of group of 
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genes, originally identified in yeast but also present in mouse and humans, 
that have been implicated in the control of chromatin accessibility. The SNF 
and SWI genes behave genetically as activators of the transcription of many 
different genes, though the proteins they encode do not appear to bind DNA 
(Winston and Carlson 1992). Genes isolated as suppressors of SNF and SWI 
mutations include genes that encode histones as well as the non-histone 
chromosomal protein HMG1, suggesting that a function of SNF /SWI 
products may be to reverse the repressive effects of chromatin (Winston and 
Carlson 1992). These examples suggest that the reversal of chromatin-based 
repression is a common component of transcriptional activation. In addition, 
the MMTV example also suggest that chromatin can repress transcription by 
inhibiting the binding of gene-specific regulators to a DNA regulatory region 
as well as by inhibiting the assembly of the general transcription machinery 
at the core promoter. 
Mechanisms for specificity of DNA-binding 
Once a DNA regulatory region has been rendered accessible, 
regulatory factors must occupy it in order to control transcription (although 
the arguments made below can also be applied to situations in which 
accessibility and occupancy are functionally linked). DNA regulatory regions 
that drive transcription in a very restricted pattern are often composed of 
multiple factor recognition sites that are each important for expression. Many 
of these essential elements contribute to very different patterns of 
transcription when they are present in other DNA regulatory regions. An 
excellent example is the muscle-specific human a-cardiac actin promoter 
which contains individual potential binding sites for the MyoD, SP1, and 
serum response (SRF) regulatory factors (Sartorelli et al. 1990). Mutation of 
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any one of these factors binding sites completely extinguished the 
transcription of this gene. Though they are essential for muscle-specific 
expression of the a-cardiac actin gene, when located in other regulatory 
regions adjacent to different regulatory elements the SP1 and SRF binding 
sites are each capable of contributing to transcriptional activation in a variety 
of other cell-types. Thus DNA regulatory regions provide a series of sites for 
individual protein:DNA interactions, and the function of the regulatory 
region relies extensively on how these regulatory factors interact. 
The biochemical properties of the regulatory factors provoke as many 
questions as they answer. In vitro experiments have established that cells can 
contain multiple factors that recognize a single binding site and that a single 
factor can recognize more than one binding site (Lamb and McKnight 1991). 
In addition, a cell's nucleus may contain multiple factors capable of 
recognizing an isolated DNA regulatory element in vitro, yet that site may be 
unoccupied in vivo (Becker et al. 1987). What determines which proteins 
occupy a given site, and what determines when and where a given site is to 
be occupied? 
Protein:protein interactions to add specificity 
One possible mechanism for achieving regulatory specificity using 
factors which in isolation appear promiscuous is to require protein:protein 
interactions between the species that can bind the regulatory region to 
establish occupancy of a DNA regulatory region (Ptashne 1986). The need for 
protein:protein interactions could enforce two levels of specificity. First, 
individual regulatory factors would only bind to DNA regulatory elements 
that had adjoining sites for compatible factors . Second, the DNA regulatory 
region would be occupied only when a sufficient number of compatible 
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proteins were available. Utilizing both protein:protein and DNA:protein 
interactions would increase the effective sequence-specificity of a factor by 
increasing its binding affinity for appropriate (specific) sites relative to 
inappropriate (nonspecific) sites (Ptashne 1986). Cooperative interaction 
could also create thresholds where small changes in binding factor 
concentrations could lead to large changes in DNA regulatory region 
occupancy, analogous to the cooperative binding of oxygen to hemoglobin 
(Stryer, 1988). Thus, cooperative interactions on a DNA template would help 
establish a situation in which sufficient quantities of diverse inputs would be 
required before any regulatory occupancy occurred. This type of mechanism 
could potentially underlie the phenomena of coordinated occupancy 
triggered by stimuli as seen in vivo at the muscle creatine kinase (Mueller and 
Wold 1989) and IL-2 DNA regulatory regions (chapter 4 of this thesis). 
Accessibility as an integrative mechanism 
The control of regulatory region accessibility could also contribute to 
such integrative control. In the case of the glucocorticoid responsive 
enhancer element of the liver-specific tyrosine-amino-transferase gene (TAT), 
genomic footprinting studies suggest that the GR may function transiently to 
remove a nucleosome from the enhancer (Rigaud et al. 1991). The enhancer 
then becomes occupied by liver-specific factors, potentially through the 
cooperative mechanisms suggested above. Thus one could imagine this two-
step mechanism functioning to integrate two pieces of information, 
glucocorticoid exposure and cell-type identity. In the absence of either piece 
of information the enhancer would not be occupied. 
Physical basis of cooperativity 
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What could be the physical basis of cooperativity between adjacent 
DNA-binding proteins? Involvement of the DNA-binding domain in 
protein:protein interactions has been established for a number of proteins. In 
one example (Thompson and McKnight 1992), the DNA-binding protein 
GABPa weakly recognizes the "cigar" motif DNA-binding site in the ICP4 
promoter through an ETS family DNA-binding domain. It recognizes this 
cigar motif much more avidly if it is mixed with the protein GABPj3, a protein 
which does not bind DNA on its own. The two proteins interact through the 
ETS domain of GABPa and a TPLH repeat domain in the GABPI3 protein. 
This TPLH repeat also appears to interact with DNA in the GABPa/GABPj3 
complex. The protein GABPI3 interacts only with GABPa, and not with other 
ETS domain proteins. This could serve to make the cigar motif specific for 
this particular combination of factors (Thompson and McKnight 1992). Such 
bifunctional DNA-binding regions could also contribute to the cooperative 
binding interactions observed on other DNA elements which contain adjacent 
binding sites for factors whose individual patterns of expression are different 
than the regulatory function of the element, such as the OAP40/0CT site of 
the IL-2 promoter (Ullman et al. 1991). 
Mutational studies of DNA regulatory regions such as IL-2 
demonstrate that multiple individual factor binding sites can collaborate 
despite being dispersed over hundreds of base pairs (summarized in chapter 
4 of this thesis). Cooperativity between DNA-binding factors is still possible 
even when the binding sites are separated by multiple turns of the DNA 
helix, often involving bending the intervening DNA (Ptashne 1986). In cases 
where binding sites are not adjacent, the interactions might involve greater 
contributions from protein:protein interaction domains distinct from the 
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DNA-binding region. In fact, a number of DNA-binding proteins contain 
multiple oligomerization domains. For example, the E2A proteins contain 
leucine zipper domains in a region of the protein separate from the well-
characterized DNA-binding and HLH domains (Murre et al. 1989). Such 
separate domains could serve to link a DNA-bound E2A protein to a protein 
bound elsewhere, though this has not been demonstrated. In addition, the 
GABPJ3 protein which binds at the cigar motif of the ICP4 promoter in a 
complex with GABPa, also has a separate oligomerization domain through 
which it dimerizes with itself (Thompson and McKnight 1992). Thus the 
GABP complex forms a tetramer, which is especially suited to the two cigar 
motifs located near one another at the ICP4 promoter. Cooperative 
interactions between separate gene-specific DNA-bound factors could also be 
through non-DNA-binding proteins. These proteins could either be gene-
specific regulators or, potentially, more general factors such as coactivators 
that might link together multiple proteins by simultaneously interacting with 
their activation domains. Thus cooperativity can be mediated through a 
variety of different particular strategies, but all involve DNA:protein and 
protein:protein interactions. 
DNA regulatory region as template for assembly of a series of 
interdependent regulatory factor:regulatory factor:DNA complexes 
In summary, one might propose occupancy is governed by a series of 
cooperative assembly events across a DNA regulatory region. An initial level 
might involve intimate contact between proteins that recognize adjacent sites. 
The stability of these complexes would th~n be dependent on interactions 
with other, more distantly bound regulators. The first level of interactions 
would be very sensitive to changes in spacing between regulatory elements, 
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whereas the subsequent interactions would be more tolerant of changes in 
spacing between individual regulatory sites (Ptashne 1986). The DNA would 
thus serve as a template for the assembly of the complex. As noted by Lamb 
and McKnight (1991), many of the protein:protein interactions involved in 
such an assembly would be relatively weak and require the DNA template in 
order form. One example of such DNA-mediated protein:protein interaction 
has been shown for Pit-1 which dimerizes only when bound to its DNA 
recognition site (Ingraham et al. 1990). Such DNA facilitated protein:protein 
interaction could be a major way in which a DNA regulatory region 
integrates information. 
Cooperativity of transcriptional activation 
Occupancy of the DNA regulatory region is only the first part of 
transcriptional regulation. The activation or repression of the core promoter 
is the second part and is an equally likely target for control. The potential for 
cooperative activation was tested in an experiment using GAL4-VP16 (Carey 
et al. 1990). As the number of GAL4 binding sites was increased (in the 
presence of sufficient amounts of GAL4-VP16 to saturate all binding sites), 
the amount of transcription increased in a greater than linear fashion. This 
apparent cooperativity of activation was called synergism, and was also 
observed between multiple different regulatory factors (Lin et al. 1990). 
Synergism could provide an additional way in which multiple inputs could 
be integrated at a regulatory region. In this case, multiple activation domains 
would need to be assembled to effectively activate transcription. Models in 
which combinations of different regulatory factors activate transcription more 
effectively than a similar number of copies of a single factor have also been 
proposed (Han et al. 1989). Thus, even though multiple factors could be 
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bound to a DNA regulatory region, unless a sufficient number or 
combination of functional activating domains were present no transcriptional 
activation might occur. In this case as well, the heart of the integrative effect 
would be that the output is different than the sum of its parts. 
Interaction between repressors and activators 
This discussion has addressed only positive levels of control. There 
are a number of DNA regulatory regions that are known to be negatively as 
well as positively controlled. This has been especially well studied in the 
even-skipped (eve) stripe two enhancer DNA regulatory region of Drosophila 
(Small et al. 1991). This DNA regulatory region senses position along the 
anterior /posterior axis of the embryo based on the relative levels of multiple 
regulatory factors. This enhancer integrates the relatively gradual 
concentration gradients of several factors into a very sharply bounded 
domain of expression, creating large differences in gene activity between 
adjacent nuclei in the embryo. A single gradient could be used to create 
sharp boundaries through a relatively simple cooperative binding or 
activation mechanism, but judging the relative levels of different regulatory 
factors is more complicated. As indicated above, oligomerization of the 
different factors can assist in integrating this information at the individual 
factor level. However, this strategy might not provide sufficiently tight 
regulation to form precise boundaries of gene activity. For example, relying 
on Id to inhibit MyoD function works well only if the differences in the levels 
of the factors involved are relatively large. In the case of the eve stripe 2 
enhancer where subtle differences need to be acted on precisely, combining 
cooperative interactions with competition between negative and positively 
acting factors could provide the necessary sensitivity. Small et al. have 
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suggested a system for the formation of the posterior boundary of stripe 2 
(Small et al. 1991). The binding of the Kruppel gene product to one or two 
sites that overlap sites for the activator bicoid was hypothesized to disrupt the 
potentially cooperative binding of the activators bicoid and hunchback to their 
multiple sites. However, an alternative model in which repression is exerted 
not through a competition for binding sites, but through antagonism of 
activation cannot be excluded. The net effect of a scheme of interaction like 
that proposed for the eve stripe 2 element is that mild differences in 
individual regulators are amplified into large changes in transcription. 
Modulation of transcriptional level 
DNA regulatory regions control not only whether there is 
transcription, but the level of transcription as well. Therefore, once a 
threshold of stable occupancy and transcriptional initiation has been 
established, additional interactions need to be accommodated to provide 
more subtle alterations in level of expression. The transcriptional 
upregulation of the constitutively active mouse metallothionein-I promoter 
upon exposure to metal provides one example of how the level of 
transcription can be controlled. Genomic footprinting showed that this 
upregulation is accompanied by the binding of additional factors to its 
regulatory region (Mueller et al. 1988). A quite different mechanism is used 
in the glucocorticoid-dependent upregulation of TAT promoter activity 
(Rigaud et al. 1991). In TAT the upregulation involves the occupancy of a 
previously unoccupied glucocorticoid-responsive enhancer. Thus 
modulation of ongoing transcription can involve the modest remodeling of 
protein:DNA and protein:protein interactions on an already occupied DNA 
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template as well as the activation of additional DNA regulatory elements that 
can cooperate with those already present. 
IV) TAKING IT ALL APART: FIGURING OUT HOW REGULATORY 
REGIONS WORK 
The question of how information is integrated by DNA regulatory 
regions is clearly one of the most important questions to be understood in 
how transcription occurs in response to environmental and developmental 
cues. In the above section I discussed several integrative strategies that could 
be used together for appropriate regulation: DNA regulatory region 
accessibility, cooperative and competitive DNA occupancy, and synergistic 
transcriptional activation. In vivo footprinting experiments such as those 
described below suggest that while some DNA regulatory regions respond to 
signals with a change in the occupancy of factors, other regulatory regions 
respond by changing the activity of factors already bound to the regulatory 
region. To achieve an understanding of how particular DNA regulatory 
regions function, a number of different types of experimental approaches 
must be pursued. I will briefly describe the basic experimental approaches, 
discuss their limitations, explain why I have worked on the development of 
in vivo footprinting techniques, and finally, what has been learned through 
my investigations of in vivo protein:DNA interactions. 
Cis-element analysis 
An essential component of understanding transcriptional regulation is the 
definition and dissection of DNA regulatory regions through cis-element 
analysis. Cis-element analysis is often performed by fusing potential 
regulatory DNA regions to DNA sequences encoding reporter proteins 
whose synthesis can be easily analyzed. These DNA sequences are created 
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using recombinant DNA techniques and the promoter/reporter fusions are 
introduced into cells through DNA transfection techniques. The production 
of th~ reporter protein is analyzed and used to gauge the regulatory capacity 
of a DNA sequence. Once a DNA regulatory region possessing the desired 
regulatory properties has been defined, this region can be further dissected 
and individual binding sites for regulatory factors can be identified. 
Mutational analysis of individual elements can give an idea of which are 
essential for the proper regulation of a regulatory region and which may 
serve only to modulate the level of transcription. Once defined, individual 
elements can be studied in isolation. Such experiments can give an idea of 
the properties of regulatory factors that function through an element. 
However, it is often necessary to multimerize an individual element for it to 
support detectable transcription in vivo. This could change the character of 
the element as the protein:protein interactions that underlie this need for 
multimerization are probably different from the protein:protein interactions 
that govern its activity in the context of the original regulatory region. The 
major limitation of such analyses is that a regulatory region's properties are 
determined by the collaboration of individual elements that often behave 
very differently from one another when studied in isolation. Mutational 
analysis of the intact DNA regulatory region can help establish the existence 
of collaboration between individual elements, but it does not allow one to 
determine the biochemical mechanisms used in that collaboration. 
Additional interpretational complications are inherent in the nature of 
most cis-element analysis. DNA regulatory regions must be removed from 
their native chromosomal locations in order to study their components. 
Chromatin structure, which can play an important role in transcriptional 
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regulation, may differ, for example, between an endogenous gene and a 
recently transfected gene, especially in transient transfection analyses where 
most copies of the regulatory region are not integrated into a chromosome. 
Clear differences in chromatin structure at the MMTV promoter were 
observed when a transiently transfected MMTV DNA regulatory region was 
compared with the identical regulatory region in the chromosome of the 
transfected cell (Archer et al. 1992). The chromosomal promoter contained a 
nudeosome (as described above) which prevented the binding of NFl to its 
recognition site. Upon glucocorticoid treatment, the glucocorticoid receptor 
bound to its site, the nucleosome was disrupted, and NFl bound to its site. 
However, the transiently transfected promoter never showed evidence of a 
bound nucleosome and NFl was bound to its site constitutively. Thus, 
although cis-element analysis is indispensable in the study of transcriptional 
control, it is limited in what mechanistic insight it can provide into the control 
of endogenous promoters. 
In vitro biochemistry 
In vitro biochemistry, involving cell-free experiments using cell 
extracts and purified factors (e.g., in vitro transcription reactions and 
electrophoretic mobility shift assays), is another essential tool for gaining an 
understanding of transcriptional control mechanisms. In vitro biochemistry 
can be used to describe in detail the interaction of regulatory factors with 
DNA regulatory elements and the mechanisms by which regulatory factors 
affect the activity and assembly of the basic transcriptional machinery of the 
cell. As we have discussed above, regulatory factors function in vivo in the 
context of a multicomponent protein:DNA complex. Despite the inherent 
difficulty of trying to accurately simulate this process in vitro, an enormous 
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amount of mechanistic insight has been obtained. However, the selection of 
reaction components, their concentrations and the post-translational 
modifications that are made to them will all influence the results obtained. 
This makes it essential to combine in vitro results with in vivo observations to 
confirm that the in vitro results accurately reflect in vivo processes. In vitro 
observations are indispensable for a mechanistic understanding of 
transcription in vivo, but they cannot stand alone. 
Genetic analysis 
Genetic analysis of transcriptional control can identify key components that 
may be biochemically difficult to obtain and can allow the pathways in which 
different components interact in the living organism to be defined. For 
example, much of the understanding of the eve stripe 2 enhancer element is 
based on genetic data (Small et al. 1991). However, genetic analysis alone is 
somewhat limited in its ability to determine the detailed biochemistry of the 
transcriptional process. 
In vivo footprinting 
Cis-element analysis, in vitro biochemistry, and genetic analysis each 
provide essential information, but each have their own limitations in what 
information they can provide about the biochemical mechanisms at work in 
vivo, in an intact cell. An additional approach which complements these is 
the in vivo biochemical approach of in vivo footprinting. In vivo footprinting 
provides information about when and where regulatory factors are bound to 
a DNA regulatory region in the intact cell. Knowing when and where 
regulatory factors are bound to DNA can provide substantial information 
about such questions as whether DNA occupancy or transcriptional 
activation is likely to be the limiting step at a particular DNA regulatory 
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region. · Furthermore, it can also provide information about the function of 
the core promoter, such as whether a complex is assembled there and 
whether a paused polymerase is likely to be present (Giardina et al. 1992). 
LMPCR 
In vivo footprinting in organisms with large genomes (such as 
mammals) was initially introduced by Ephrussi et al. in 1985. However, it 
was not widely utilized as it was technically challenging and even when 
successful resulted in a low level of signal and an unfavorable signal to noise 
level. Several years ago, Paul Mueller and I devised the ligation-mediated 
polymerase chain reaction (LMPCR) strategy for performing genomic 
footprinting. Paul Mueller's original LMPCR procedure substantially 
improved the absolute level of signal, the signal to noise ratio, and decreased 
the amount of starting material needed for in vivo footprinting (Mueller and 
Wold 1989). However, the quality of the result varied in a regulatory region-
dependent fashion. Some DNA regions could not be visualized, while many 
others contained spurious bands which destroyed much of the in vivo 
footprint data. The third chapter of this thesis describes alterations made to 
LMPCR which improved the quality of genomic footprinting and 
substantially expanded the range of DNA regulatory regions that could be 
successfully examined through in vivo footprinting. 
In vivo footprinting of IL-2 
The fourth chapter of this thesis describes the use of this LMPCR in 
vivo footprinting procedure to investigate the transcriptional regulatory 
mechanism involved in the induction of IL-2 RNA synthesis in stimulated 
mouse T cells. Stimulation of the EL4 mouse thymoma cell line (EL4 T cells) 
was shown to trigger the coordinated occupancy of multiple regulatory 
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elements in the IL-2 DNA regulatory region in vivo. Further evidence for the 
integration of multiple inputs at the IL-2 regulatory region by the mechanism 
of coordinated occupancy was obtained through the use of the 
immunosuppressant drug CsA. Through the use of electrophoretic mobility 
shift assays to characterize the presence of regulatory factors in nuclear 
extracts, CsA was shown to block the DNA-binding activity of some, but not 
all of the regulatory factors activated in stimulated EL4 T cells. However, 
CsA blocked the binding of all these factors to the IL-2 regulatory region in 
vivo. Thus CsA was shown to block IL-2 transcriptional induction by 
blocking the coordinated occupancy of the IL-2 regulatory region by 
regulatory factors. IL-2 is synthesized as a result of the T cell integrating 
multiple internal and external signals. The observed multi-component, 
coordinated assembly appears to be an essential component of this 
integrative process. 
In vivo footprinting of the promoter of the acetylcholine receptor 8-subunit 
The use of LMPCR in vivo footprinting to observe the pattern of in vivo 
protein: DNA interactions. at the 8-AChR regulatory region gives a result very 
different from that seen for IL-2. The 8-AChR regulatory region was 
occupied by multiple factors in undifferentiated myoblasts, though this 
regulatory region is not transcriptionally active in these cells until they have 
differentiated into myocytes. Upon differentiation, the pattern of in vivo 
interactions at the 8-AChR regulatory region was unaltered. Therefore, 
activation of 8-AChR transcription may be due to alterations in the ability of 
bound regulatory factors to activate transcriptional initiation, the replacement 
of previously bound factors with other factors at the same sites, or alterations 
in transcriptional elongation. However, the MCK enhancer region, which has 
46 
the same pattern of transcriptional activation in the cells examined, was 
unoccupied until it activated transcription. Therefore, the o-AChR and MCK 
enhancer use quite different activation mechanisms even though their pattern 
of expression is similar. 
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Chapter 2 
Tissue-specific expression from a 
compound TATA-dependent and 
TAT A-independent promoter. 
(This chapter was published in Molecular and Cellular Biology 10: 5646-5654.) 
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We have found that the mouse metallothioneln-I (MT-I) gene promoter functions In an unusual, compound 
manner. It directs both TATA-dependent and TATA-independent modes of transcription in vivo. The 
TA TA-dependent message Is initiated at the previously characterized + 1 transcription start site and is the 
predominant species in most tissues. In many cell types it is metal Inducible. The TAT A-independent initiation 
sites are distributed over the 160 bp upstream of the previously characterized + 1 start site, and the RNA 
products are present in all tissues examined. Only in testis, however, do the TAT A-independent transcripts 
predominate, accumulating to highest levels in pachytene-stage meiotic cells and early spermatids. Unlike the 
TAT A-dependent +1 transcript, these RNAs are not Induced by metal, even in cultured cells In which the +1 
species is induced. Transfectlon studies of site-directed mutants show that destruction of the TAT A element 
drastically alters the ratio of. the two RNA classes in cells in which the + 1 transcripts normally dominates. In 
TATA-mlnus mutants, the TATA-independent RNAs become the most prevalent, although they remain 
refractory to metal Induction. Thus, the MT -I promoter utilizes two different types of core promoter function 
within a single cell population. The two different types of core promoters respond very differently to 
environmental stimuli, and the choice between them appears to be regulated in a tissue-specific fashion. 
Two different classes of promoter structure and function 
have been described for RNA polymerase II transcription in 
eucaryotes. The first class includes the ml\iority of genes and 
is characterized by the presence of a TAT A element which 
specifies the site of transcription initiation, usually about 30 
nucleotides downstream. Extensive genetic and biochemical 
evidence has shown that the TAT A element plays a signifi-
cant role in start site selection and in specifying the fre-
quency of transcriptional initiation (3, 5, 12, 15, 17, 19, 22, 
25, 40). By itself, a TATA element is sufficient to stimulate 
specific transcription in vitro, though it does so with low 
efficiency in vivo in the absence of auxilliary elements (32, 
45). Based on these properties, the TATA element can 
reasonably be considered to constitute a type of core pro-
moter. The activity of such a core promoter is dependent in 
vivo on interactions with other protein-DNA complexes. 
These modulators include transcriptional enhancers, which 
can act at considerable distances from the core promoter, as 
well as more proximal upstream elements that are less 
flexible than enhancers in their orientation and distance 
requirements (38). In the current view, enhancers and up-
stream elements mediate environmental and developmental 
regulation of transcription initiation by positively or nega-
tively modulating the activity of the core promoter complex 
(25, 38). 
A second class of core promoters lacks a detectable TAT A 
element. Some of these initiate transcription at a single 
position (50), while others initiate transcription at multiple 
sites over an extended region (16, 26, 31, 35, 37, 44, 47). The 
nature and extent of mechanistic differences between 
TATA-dependent and TATA-independent modes of tran-
scription initiation are not presently known. ~n gene~ de-
scribed to date, a promoter has been considered either 
TATA dependent or TATA independent, with developmen-
• Corresponding author. 
tal regulation determined by the action of separable positive 
or negative modulators on this core promoter structure (or in 
some cases more than one core promoter of the same type, 
e.g., two TATA elements [51]). Here we describe an inter-
esting departure from this view of fundamental promoter 
classes and their developmental regulation based on the 
study of promoter structure and function for the mouse 
metallothionein-1 (MT-1) gene. 
The MT-1 gene is constitutively expressed in many tissues 
and can be induced to higher levels by exposure to heavy 
metals (13). This induction has a major transcriptional com-
ponent (13) and can be attributed in large part to the positive 
action of upstream metal-regulatory elements (MREs) on the 
TATA-dependent core promoter (7, 49, 52). Here, closer 
examination shows that there is also a non-metal-inducible 
population of MT-1 RNAs that are initiated upstream of the 
TATA element and, at least in cultured fibroblasts, are 
TATA independent. Thus, the MT-1 promoter simulta-
neously uses both TA TA-dependent and TAT A-independent 
transcription regimes which are divergent in their response 
to environmental stimuli. Moreover, there appears to be 
profound tissue-specific regulation in the choice of core 
promoter mechanism. Upstream RNAs similar to those seen 
in fibroblasts and many other cell types are the predominant 
species in the testis. Testis has previously been noted as 
unique among the tissues which have been studied in its 
regulation of MT-1 RNA. Despite possessing a high basal 
level of MT-1 RNA, it does not respond to cadmium (Cd) 
accumulation with a rapid increase in MT-1 transcripts (13);. · 
Thus, MT-1 is a naturally occurring case of compound cor\!' 
promoter function, and the choice between the modes of. · · 
transcriptional initiation appears to be regulated in a tissue-
specific fashion. Previously, this had not been considered a 
choice but rather an intrinsic property of gene architecture. 
These observations contribute to a revised view of the 
interaction of regulatory elements, including MREs, with t)le 
two classes of initiation complex. 
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MATERIALS AND METHODS 
Constructs and probes. Standard procedures and manufac-
turer's instructions were used in constructing plasmids and 
synthesizing RNA transcripts. Four MT-I probes were used. 
The 5'-end genomic probe was generated from pSP6-MT-I 
(gift of P . Mueller), which contains mouse MT-I genomic 
sequences in the pSP64 vector. pSP6-MT-I was cut with 
BstEII and transcribed with SP6 RNA polymerase. pMT-IAi 
(gift of R. D. Palmiter) was used to create pMT-ISH and 
pMT-IBH. pMT-ISH was created by inserting a 
Sacl-Hindiii fragment of pMT-IAi into Sacl- and Hindiii-
cut pT3m-19 (Bethesda Research Laboratories, Inc.). 
pMT-ISH was cut with EcoRI and transcribed with T7 RNA 
polymerase to generate the full-length eDNA probe. pMT-
IBH was created by inserting a Bglli-Hindiii fragment of 
pMT-IAi into BamHI- and Hindiii-cut pBluescriptSK+ 
(Stratagene). pMT-IBH was cut with Xbal and transcribed 
with T3 RNA polymerase to generate the 3' eDNA probe. 
pMT-INT (gift of P . Mueller), a Bglli-HinPI fragment of 
pMT-IAi inserted in BamHI- and Acci-cut pT3m-19, was 
cut with EcoRI and transcribed with T7 RNA polymerase to 
generate the internal eDNA probe. pBs- (Stratagene) was a 
gift of S. Tavtigian. pMTCAT (30) is a derivative of 
pBluescriptKS- (Stratagene), which contains the MT-I pro-
moter EcoRI-Bglii fragment, the chloramphenicol acetyl-
transferase (CAT) sequence of pSV2cat, and the simian 
virus 40 splicing and poly(A) addition signals. Oligonucle-
otide-directed mutagenesis was used to create pMCSPA (gift 
of L. J . Maher and S. J. Salser), the Sp1 site mutant 
derivative of pMTCAT, and pMCT, the TATA mutant 
derivative of pMTCAT. The substitution of TCGAGA for 
the wild-type TATAAA sequence in pMCT was anticipated 
to disable TATA element function. The double mutant 
TAGAGA has previously been shown, in studies in which 
the TAT A-binding transcription factor TFIID from Saccha-
romyces cerevisiae was used to complement a mammalian 
transcriptional extract, to drastically reduce transcription 
from the adenovirus type 2 major late promoter in vitro (6). 
Furthermore, the binding affinity of yeast TFIID for the 
double mutant adenovirus major late promoter is similar to 
its affinity for nonspecific DNA (21). 
CeU culture and Induction. P cells (derived from L cells as 
described in reference 29) were maintained in dialyzed calf 
serum (39). Eight hours prior to harvesting for RNA, fresh 
medium with or without 6 f.I-M CdS04 was added. Cells for 
transfection were plated at 3.7 x 105 per 10-cm dish and 
transfected by a standard calcium phosphate coprecipitation 
27 h later. Each plate received 10 f.l-g of test plasmid 
(pMTCAT, pMCT, pMCSPA, or pBS-), 10 f.l-g of L cell 
DNA, and 1 f.1-g of pY3, which confers resistance to hygro-
mycin B. Mter 11 h of DNA exposure, cells were refed with 
fresh medium. After 24 h, cells were refed with fresh 
medium containing 200 f.l-g of hygromycin B per mi. The cells 
were refed every 3 days with fresh selection medium until 
they had spent 17 days in selection medium. More than 90 
separate colonies were obtained on each plate. Each test 
plasmid was used to transfect three plates, and the pools 
obtained were maintained and analyzed separately. No 
viable colonies were recovered from a control plate which 
had received no DNA. Cells were split three times prior to 
RNA analysis and were maintained in selection medium. 
Eight hours prior to harvesting for RNA, fresh hygromycin-
free medium with or without 6 f.I-M CdS04 was added. 
Animals and Induction. Male mice (8 to 15 weeks old) of 
strains DBA/2J, C57BU6J (both obtained from Jackson 
Laboratories, Bar Harbor, Maine) and BDF1 (offspring of 
DBA x C57BL m·atings) were used. No strain or age 
variation in MT RNA expression was noted, and 15-week-
old DBA/2J mice were used fl!r quantitation. Mice were 
injected subcutaneously with 200 f.l-l of H20 (or 0.9% NaCI) 
with or without CdS04 (10 mg of Cd per kg of mouse body 
weight) 3 h before the mice were sacrificed by cervical 
dislocation. Tissues were flash-frozen in liquid nitrogen and 
stored at -so•c until RNA was isolated. 
Pretreatment of mice with Cd was as described in refer-
ence 42, using CdS04 instead of CdC12 • Bodies, testes, and 
kidneys were weighed after the mice were sacrificed. No 
body or organ weight differences were noted between mice 
pretreated with daily injections of saline (n = 5) and those 
receiving saline with CdS04 (0.25 mg of Cd per kg) (n = 6) 
after 12 days. The testes of mice given a single injection of 1 
mg of Cd per kg after pretreatment with saline (n = 6) and 
examined 13 days later weighed approximately half as much 
as those from mice injected with saline after the saline 
pretreatment (n = 5). There was no effect on body or kidney 
weight. Mice pretreated with CdS04 showed no such de-
crease in testicle weight (n = 4). 
RNA preparation. RNA was prepared from L cell deriva-
tives (P cells) as described before (11, 39). RNA was 
prepared from mice as described in reference 11, with the 
addition of a second organic extraction. Purified testis cell 
type and mutant mouse RNAs were provided by Kelly 
Thomas and Mel Simon (sample set 1 [reference 53]) and by 
Debra Wolgemuth (sample set 2 [reference 54]). These 
RNAs were prepared by LiCl precipitation (9). RNA con-
centrations were determined by the A 260• DNase treatment 
of RNAs did not alter the results. 
RNase protection. RNase protection assays were per-
formed as described before (29, 56) with the following 
modifications. RNA probes were isolated prior to use from 
either N,N'-bis-acrylylcystamine acrylamide (Bio-Rad Lab-
oratories) or conventional acrylamide gels. The type III 
preparation of small yeast RNAs (Sigma catalog no. R-7125) 
was used as carrier RNA and in lanes labeled tRNA control. 
Total MT-I RNA levels were determined by using the 5' 
genomic probe and the internal eDNA probe. Protected 
bands were excised from the gel, and the radioactivity was 
counted. Counting efficiency was determined by counting 
gel-isolated dilutions of probe. Transcript abundances were 
also determined from autoradiographs of 5' genomic probe 
RNase protection experiments and MT-I oligonucleotide 
primer extensions (see below) with an LKB XL densitome-
ter. The densitometric results were generally consistent with 
the results from scintillation counting. 
Primer extensions. Primer extensions were performed with 
avian myeloblastosis virus reverse transcriptase (Life Sci-
ences) (27). Reverse transcription of endogenous MT-I RNA 
was primed with an oligonucleotide (5'-CGGAGTAAGT 
GAGGAGAAGGTACTC-3') complementary to nucleotides 
+45 through +23. A 0.1-pmol amount of gel-isolated, 5'-end-
labeled primer was used ·in each reaction mixture. Signal 
linearity was confirmed by analyzing dilutions of a single 
RNA sample. The results of RNase protection experiments 
carried out on all samples in Fig. 1C (Fig. 1B and data riot 
shown) indicate that the primer extension products in Fig. 
1C accurately reflect MT-l RNA termini. Primer extension 
products were quantitated by densitometry as above. Re-
verse transcription of MT-CAT fusion RNAs was primed 
with an oligonucleotide (5' -ATATCAACGGTGGTAT ATCC 
AGTGA-3') complementary to CAT sequences. It lies 143.to 
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119 bp downstrea m of the MT-I +1 site in the pMTCAT 
plasmid. 
RESULTS 
Expression pattern of the multiple species of MT-1 RNA. 
MT-I RNA was examined in tissues from DBA/2J, C57BU 
61, and BDF1 mice, in NIH 3T3 cells, and in a n L cell 
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FIG. 1. (A) Structure of the mouse MT-1 gene and the antisense 
probes used in RNase protection and primer extension assays. 
Sequence is from reference 18, with an additional A at -112 (39). 
Unshaded boxes, Exon and promoter sequences; stippled boxes, 
introns; black boxes, sequences downstream of 3' cleavage and 
polyadenylation site (A.); thin horizontal lines, vector sequences. 
Restriction sites are numbered according to complementary nucle-
otides retained in derived probes. (B) RNase protection analysis 
performed with 5' -end genomic probe. Sample RNA (8 IJ.g) plus 
tRNA (30 IJ-8) were used in lanes 1, 2, and 4 to 7; 30 IJ.g of tRNA 
alone was used in lane 3. Products were initially sized by using DNA 
markers and subsequently assigned to specific start sites by com-
parison with primer extension results. Longer exposures show 
upstream RNAs present in the kidney. The smear near -28 in lane 
7 is artifactual. Please note that because RNase protection probes 
are continuously labeled, the specific activity (disintegrations per 
minute per mole) of each protected product increases with product 
size. hnRNA, heterogeneous nuclear RNA (unspliced + 1 RNA). (C) 
Primer extensions performed with the MT-1 oligonucleotide. An 
8-IJ.g amount of RNA was used in each lane (except lane 15, to which 
no RNA was added). Product identities were determined by com-
parison with adjacent lanes generated by dideoxy sequencing of 
MT-1 with the same oligonucleotide. Subsequent analysis of multi-
ple independent preparations of RNA indicated that the apparent 
metal induction of upstream RNA in liver shown in this figure was 
anomalous and that upstream RNAs in liver were actually slightly 
repressed by metal. Intest., Intestine. 
derivative (P cells [29]) by RNase protection (Fig. lB and 
data not shown) and primer extension (Fig. 1C) . The profile 
of MT-I RNA in testis (Fig. 1B, lanes 3 and 4 , and Fig. 1C, 
lanes 1 and 2) was dramatically diffe rent from that found 
elsewhere. The expected t ranscript, with its 5 ' end a t the 
previously described + 1 site (18), constituted only 15% of 
the total MT-I RNA in testis. The remainder were transcripts 
that extended well upstream. (To facilitate quantitation , we ' 
have operationa lly grouped the many species of transc ripts 
into six major groups, as indicated in Fig. 2B. Total MT-r'" 
and individual start site RNA da ta are presented in the Fig. 
2A histograms.) Although thi s 5' heterogeneity was most 
striking in the testis, close inspection of both primer exten-
sion and RNase protection experiments showed that all 
sources tested posse ssed a complex array of MT-I 5' ends : 
For example, L cells, while producing high levc;ls of the + 1 
62 
VOL. 10, 1990 COMPOUND TATA-DEPENDENT!TATA-INDEPENDENT PROMOTER 5649 
A 
Total MT-1 RNA Start site distribution of Mlf-1 RNA 
Testis LCell Kidney 
.q .q 2~-
0 
~3000 z a: "'40 
"' ilJ .,1500 a. a. ,. 30 ~2000 CD Ui : ~ ' ~1000 #20 Q. .2-1i1000 ~: 1 : u 0 10 .. ifi ' ' .. 500 I 0 ·~ -c c .. ,.~* B C !! w.· 8 C t= 0 =='·=-=· .... 0 __  
A B C A B c 
START SITES START SITES 
B 
MT-1 promoter and transcript start sites 
F E D C B A Start sites grouped 
for quanlllatlon I 
·200 ·180 
I I 
·120 · 100 ·80 -60 ·40 
I I I I I 
·20 
I 
rrtr rrrrt tt rrt t t TRANSCRIPT 
STARTS 
--~ 
j SP1 MRE·E G-BOX MRE·C G-BOX AP-1 MRE-8 MRE·A TATA FIG. 2. (A) Transcripts per 26 pg of RNA, the amount of RNA in an L cell (4). The quantitation procedure is described in Materials and 
fthods. Transcriptional start sites were grouped into six clusters to ease analysis (see panel B). RNA termination sites by group: A, + 3 to 
-~; B, - 25 to -35; C, -39 to -45; D, - 51 to -75; E, - .82 to -119; F, -133 to -146. (B) Map ofMT-I promoter, with arrows indicating 
the position of each discrete start site Gudged by its appearance as a unique entity in both RNase protection and primer extension 
experiments) and with the groupings used in quantitation indicated. Groupings reflect the smallest regions which could be reliably excised 
from a gel and/or densitometrically integrated. Boxes indicate potential DNA-protein interaction sites (39). The MREs show metal-inducible 
dimethyl sulfate (DMS) protection in L cells in vivo. The distal Spl site binds Spl in vitro and shows an Spl-like footprint in L cells in vivo. 
The proximal Spl site binds Spl weakly in vitro but does not shown an Spl-like footprint in L cells in vivo. The MLTF site shows MLTF-like 
DMS protection in L cells in vivo. The G element (G-BOX) is a conserved sequence feature of the MT gene family with no known function. 
The potential AP-1 site (1) has not been shown to interact with this factor. 
transcript, expressed essentially the same set of upstream 
RNAs as the testis, although many of these species (e.g., 
-96) were expressed at much reduced levels (Fig. 18, lanes 
1 through 5, and Fig. 2), while kidney expressed lower levels 
of upstream RNA than either testis or L cells and used a 
different set of upstream initiation sites (Fig. 18, lanes 6 and 
7; Fig. 1C, lanes 3 and 4; and Fig. 2). Inspection of the MT-I 
promoter sequence revealed no other TAT A homologies in 
this region and no concordance between the upstream start 
sites and potential "initiator" elements of the type shown to 
fix the start site in the TAT A-less mouse terminal deoxynu-
cleotidyltransferase gene (50). The MT-I upstream DNA also 
lacked any identifiable HIP1-binding sequences, which di-
rect start site selection at one of the several start sites in the 
mouse dihydrofolate reductase (dhfr) gene (33). 
Cd administration induced only the +1 RNA species. The 
+ 1 RNA levels increased by at least 40% and commonly 
over 25-fold in all cells and tissues surveyed except testis 
(Fig. 1C, short exposure), in agreement with previous deter-
minations of total MT-I RNA content (13). Steady-state 
levels of the upstream MT-I RNAs were relatively unaf-
fected by Cd. The greatest change in the upstream RNAs 
was detected in L cells, where the longer transcripts de-
creased 40 to 60% after metal treatment (Fig. 18, lanes 1 and 
2; Fig. 2); testis and kidney showed smaller but reproducible 
diminutions (Fig. lB, lanes 4 and 5; Fig. lC, lanes 1 through 
4; Fig. 2). These upstream, non-metal-inducible transcripts 
were a specific property of MT-I rather than a ubiquitous 
feature of metallothionein genes. In contrast to MT-I, the 
closely related mouse metallothionein-11 (MT-11) (48) tran-
scripts showed little upstream heterogeneity at the 5' end 
and exhibited metal induction behavior paralleling that of the 
MT-I +1 RNA (data not shown). 
The many species of MT-1 RNA differ only at their site of 
initiation. We examined MT-I RNA from various sources to 
see whether the upstream initiation sites produced RNA:s 
substantially different from the traditional + 1 site RNAs. 
RNA gel blots , containing samples from testis and kidney;. 
were probed with an oligonucleotide specific for upstream 
RNA and with a n oligonucleotide which would hybridize to 
both upstream and + 1 RNAs. In each experiment only one 
general size species of MT-I RNA was detected (data not 
shown), indicating no gross structural differences in the body 
of the RNA. More sensitive assays for structural heteroge-
5650 GARRITY AND WOLD 
FIG. 3. RNase protection assays performed with the full-length 
eDNA probe (lanes 1 to 7) and 3'-end eDNA probe (lanes 9 to 13). 
Sample RNA (3.4~J.g) plus tRNA (30 11-g) was used in lanes 2 to 7 and 
lanes 10 to 13; 30 II-& of tRNA alone was used in lanes 1 and 9. 
Products were sized by using Hpaii-cut pBR322 and pUC19 (lane 
8). Products were assigned to specific start sites based on compar-
ison with Fig. 1. Longer exposures showed upstream RNAs present 
in the kidney. Note that the complementarity of the full-length 
eDNA probe extended only to -153. The asterisk denotes the 
predicted protection product of the 3'-end eDNA probe. 
neity were also performed. 3'-End eDNA and full-length 
eDNA probes (Fig. 1A) were used in RNase protection 
assays. The 3'-end eDNA probe (Fig. 3, lanes 9 to 13) 
required appropriate splicing and 3' cleavage of the RNA to 
yield the product indicated by the asterisk in Fig. 3. The 
amounts of this product in testis and kidney were consistent 
with our total MT-1 RNA measurements and so represented 
the vast majority of MT-1 RNA species. Furthermore, the 
full-length eDNA probe (Fig. 3, lanes 1 to 7), which is 
sensitive to the transcription initiation site as well as splicing 
and 3' cleavage, recapitulated the start site distribution seen 
in RNase protection with the 5'-end genomic probe (Fig. 1B, 
lanes 1 to 7) and in primer extension with the MT-1 oligonu-
cleotide (Fig. 1C, lanes 1 to 4). These data, combined with 
previous work establishing that all MT-1 RNA in testis is 
polyadenylated (55), show that, within our limits of detec-
tion, all species of MT-1 transcripts are spliced and 3'-end 
processed identically and therefore differ from one another 
only at their 5' ends. 
On the basis of the data presented thus far, it was formally 
possible that the upstream RNAs could be hitherto-undetec-
ted precursors of the + 1 species that accumulate to higher 
steady-state levels in testis. Such a pattern of 5'-end proc-
essing would be unprecedented, however, and appears un-
likely to be the case for two reasons. First, the longer RNAs 
persisted in L cells over the course of a 6-h dactinomycin 
(actinomycin D) transcriptional block instead of being 
chased into the + 1 form (or any other detectable form) by 
subsequent processing (data not shown). Also, as detailed 
below, site-directed mutation of the MT-1 TATA element 
virtually eliminated the + 1 product while leaving upstream 
RNAs intact, an observation inconsistent with a precursor-
product relationship. 
Testis sensitivity to Cd can be altered without changing MT 
RNA behavior. Metallothionein proteins bind heavy metals 
(like Cd) and can protect cells from their potentially toxic 
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effects (23). Compared with other tissues, testis shows an 
unusual sensitivity to Cd, suffering widespread and irrevers-
ible damage at Cd doses that hare no other major effect on 
the animal (34, 43). However, treatment of susceptible 
strains with low doses of Cd protects these mice from 
testicular damage by a subsequent high dose of Cd (42). We 
reexamined these phenomena in the light of our present 
knowledge of MT RNA behavior in testis. It is possible that 
testis hypersensitivity might be due to the noninducibility of 
MT-1 and MT-11 RNAs in testis and that this noninducibility 
might be related to the unusual behavior ofMT-1 RNA there. 
A mouse strain reported to be "less susceptible" to testic-
ular damage by Cd (20), C57BU6J, was examined and 
showed no difference in basal or induced expression of MT-I 
and MT-11 (data not shown) compared with the susceptible 
strain DBA/2J. A low-level Cd pretreatment regime did 
protect DBA/2J mice from Cd-induced testis damage but had 
no discernible effect on the basal level of MT-1 RNA or 
MT-II RNA in testis, nor did it render these genes metal 
inducible in this tissue (data not shown). Thus, it is possible 
to change Cd sensitivity without modifying MT RNA expres-
sion. Although the failure of MT RNA to be induced by 
metal in testis may contribute to the organ's susceptibility to 
Cd poisoning, additional mechanisms are involved in gener-
ating resistance by the Cd pretreatment regime. 
Upstream MT-1 RNAs are the predominant species in germ 
cells of the testis. The testis is a complex organ containing 
specialized somatic accessory cells, such as Sertoli and 
Leydig cells, along with premeiotic germ cells, cells in 
various stages of meiosis, and maturing sperm. To find out 
which of these very different cell types are responsible for 
the predominance of upstream MT-I transcripts in total 
testis, RNAs from fractionated cell populations from the 
testes of mice not exposed to metal were first examined. The 
upstream RNAs were most prominent in late meiotic 
prophase (pachytene-stage cells) and remained prominent in 
the early stages of sperm maturation (round spermatids) 
(Fig. 4, lanes 3 to 7). Thus, in germ cells, the level of 
upstream RNA per unit mass of total RNA increased late in 
meiosis and then declined in the residual bodies and cyto-
plasmic fragments cast off by condensing spermatids (Fig. 4, 
lanes 1 to 7). Conversely, the level of the+ 1 RNA gradually 
declined as the germ cell population proceeded from sper-
matogonia to round spermatids and was even lower in the 
residual bodies and cytoplasmic fragments. 
Another method, independent of cell separation tech-
niques, can distinguish expression in germ cells from expres-
sion in accessory cells. Mutant mice of the Yi..&_v genotype 
lack germ cells but possess all the somatic cell types of the 
testis (36, 41, 55). The testes of Yi..&..v mice were found to 
contain substantially lower levels of upstream RNA than the 
phenotypically wild-type testes of +/Yi.." mice (Fig. 4, lanes 9 
and 10). This argues that high-level upstream MT-1 transcript 
expression is limited to germ cells. 
Can the different specie~ of MT-1 RNA encode variant 
proteins? Inspection of the 5' nucleotides of the longer 
transcripts indicated that they contained an open reading 
frame that could code for a 22-amino-acid protein (showing 
none of the cysteine-richness of the MTs) after initiation at' · 
the -91 ATG. However, there were stop codons in this and 
all other reading frames between -4 and +40, upstream of 
the previously recognized initiation codon. It therefore ap-
pears unlikely that the extra nucleotides contribute any 
information toward a larger than usual MT protein. Possible 
effects of the longer 5' leader on RNA processi~g efficiency, 
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FIG. 4. RNase protections performed with the 5'-end genomic 
probe. Sample RNA (0.5 .,.g) plus tRNA (30 .,.g) was used in each 
lane. The tRNA lane (not shown) gave no signal. Mouse age at 
preparation of sample: type A and B spermatogonia, 8 days; 
leptotene (Lept.) and zygotene (Zyg.) cells, 17 days; pachytene and 
round (R.) spermatids as indicated (in days); residual body and 
mutant mouse testes, >40 days. Lanes 1, 2, 3, 4, and 6 are from 
sample set 1. Lanes 5, 7, 8, 9, and 10 are from sample set 2. The 
practical necessity of using mice of different ages to prepare the 
various cell populations did not appear to compromise our conclu-
sions about stage specificity. The MT-1 RNA profiles of pachytene 
cells from 17-, > 60-, and >40-day-old mice were qualitatively 
similar, while the leptotene, zygotene, and pachytene cells from 
17-day-old mice were quite different. hnRNA, heterogeneous nu-
clear RNA (unspliced + 1 RNA). 
message stability, or translational regulation remain to be 
examined. 
Site-directed mutation separates MT-1 RNA species Into 
TATA-dependent and TATA-Independent classes. The pres-
ence of a group of RNAs that initiate upstream of the TATA 
homology element a nd are regulated differently than the + 1 
RNA suggested that the MT-1 promoter might be directing 
transcription in two different ways, one TATA dependent 
and the other TATA independent. We directly tested this 
possibility by constructing appropriate mutants of the MT-I 
promoter and analyzing the RNA products of each in tra ns-
fection assays. Because L celts express the same overall 
repertoire of upstream start sites as germ cells (albeit with 
quantitative variations) (Fig. 1B), they were used as trans-
fection hosts. The constructs contained MT-I sequence 
extending from 1. 7 kb upstream to 65 bp downstream of the 
MT-1 + 1 site fused to the CAT gene (30). Site-directed 
mutagenesis was used to disrupt the TAT A element by 
substitution of the sequence TCGAGA for the wild-type 
TATAAA. A construct containing mutations in the distal 
Sp1 site (GGGGCGG changed to GCCCGGG) was also 
created. This Sp1 site binds Sp1 in vitro, is occupied in L 
cells in vivo (39), and is of interest because Sp1 activates 
TAT A-independent transcription from the dlifr promoter in 
vitro (14). 
1 2 3 4 5 6 7 8 
FIG. 5. Primer extensions performed with the transgene-specific 
MT-CAT oligonucleotide. A 9-fl.g amount of RNA from each trans-
fected cell line was used per lane. Overexposure of the autoradio-
graph necessary to see upstream RNA and mutant + 1 RNA caused 
the induction of the + 1 RNA in the wild-type (wt) and Sp1 mutant 
lanes to be underrepresented. Product identities were assigned by 
comparison with adjacent lanes generated by dideoxy sequencing of 
pMCf with the MT-CAT oligonucleotide. 
Polyclonal pools of stably transfected L cells containing 
each construct (and controls containing the plasmid pBS-) 
were made. Primer extension analysis was performed with a 
transgene-specific CAT primer on total RNA from three 
independent transformant pools for each construct (Fig. 5 
and data not shown). As expected, the wild-type MT-1-
promoted transgene produced hybrid MT-CAT RNAs which 
paralleled the endogenous MT-I RNAs in 5' -end heteroge-
neity and + 1 RNA predominance (Fig. 5 , lanes 5 and 6). The 
+ 1 RNA species was induced by metal, and the quantita-
tively minor upstream RNAs were slightly repressed. In 
sharp contrast, the TAT A mutant transgene produced pre-
dominantly the upstream RNAs (Fig. 5, lanes 3 and 4). Some 
RNA still arose from the + 1 region, but it exhibited 5' -end 
heterogeneity, a common result of eliminating the TAT A 
element from a TATA-dependent promoter. These data 
confirm that, in L cells, the + 1 RNA of the wild-type 
promoter is TATA dependent and show that the upstream 
RNAs are TATA independent. In addition to this clear 
qualitative change in RNA expression pattern, mutation of 
the TATA element ted to an apparent increase in the 
absolute amount of upstream RNA produced in each trans-
fected pool. This may imply that the TAT A-dependent and 
TAT A-independe nt transcriptional modes compete with 
each other and that ablation of the TATA e lement altered 
that competition. Howeyer, such quantitative differences 
between stably transfected potyctonal cell pools are some-
times seen even when separate pools that contain the same . 
construct are compared. At present we favor the former· 
explanation but cannot rule out the latter. •· · 
The central result of these experiments is that, in L cells , 
the upstream RNAs are independent of the MT-1 TATA 
element, while the + 1 start is TATA dependent. U ntil such 
mutations are also analyzed in transgenic mice , we cannot be 
certain that this is true in other celt types, a lthough it seems 
likely that it w ill be. Subtle results of the ~ ~ T A mutation 
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were also observed. The first concerns the upstream RNAs 
of the TATA mutant, which, like those of the parental gene, 
were slightly repressed by metal. In contrast, the residual + 1 
region RNAs of the TATA mutant retained some metal 
inducibility (Fig. 5, ·Janes 3 and 4, and data not shown), but 
the effect was small compared with the degree of metal 
induction seen in the wild-type construct. Another question 
was whether the TAT A mutation alone would switch the L 
cell pattern to a precise copy of the germ cell pattern. It did 
not do so. Given the differences already observed in the 
details of upstream RNA populations in different tissues, it 
seemed unlikely that TATA dependence alone dictates the 
pattern of upstream start site utilization. Close inspection of 
the TATA mutant RNAs in L cells supported this view; start 
sites adjacent to +1 (e.g., -5 and -12) were much more 
pronounced than in germ tissue, and the shorter upstream 
RNAs (e.g., -28 and -44) were much more prevalent than 
the longer upstream RNAs, the usual L cell pattern. Since 
the TATA mutation does not result in a complete recapitu-
lation of the germ cell RNA pattern in L cells, the unique 
germ cell pattern must be created by more than an inability 
of the TATA element to function. Nonetheless, it is likely 
that the upstream RNAs in germ cells will share the inde-
pendence of the TATA element of their L cell counterparts. 
Mutation of the distal Spl site did not have a major impact 
on RNA production (Fig. 5 , lanes 7 and 8). Therefore, in L 
cells, this element is not essential for basal expression of 
either the + 1 or the upstream MT-I RNAs and is not 
required for metal induction of the MT-I +1 RNA. In the 
transfected pools, expression from the endogenous MT-1 
gene was not affected by the presence of the various trans-
genes (data not shown), eliminating the possibility that the 
behavior of the introduced genes could be due to a promoter 
titration effect. 
DISCUSSION 
We have shown that the mouse MT-I promoter directs 
RNA transcription via both TATA-dependent and TATA-
independent mechanisms, that it functions in both ways even 
in apparently homogeneous populations of cells, and that the 
choice between modes is developmentally regulated. This 
type of compound promoter behavior has not, to our knowl-
edge, been recognized previously. Whether the two modes 
coexist temporally within a single cell or even at a single 
promoter is an interesting but unanswered question. A 
different type of compound promoter has been described for 
S. cerevisiae (2, 24, 51). Those promoters are compound in 
the sense that they possess multiple, functionally distinct 
TATA elements and therefore operate via multiple TATA-
dependent mechanisms. 
We were led to this discovery by the observation that the 
MT-1 promoter initiates transcription at many sites and thus 
produces multiple species of MT-I transcript. The well-
characterized + 1 transcript (group A in Fig. 2) is initiated 23 
nucleotides downstream of the TATA element and is TAT A 
dependent. The newly identified MT-I RNA species (groups 
B through F in Fig. 2) are initiated at a multitude of sites 
upstream of the + 1 site (most of these are initiated upstream 
of the TATA element as well) and are, in contrast, TATA 
independent. Both classes of RNA are properly spliced and 
polyadenylated. These characteristics strongly argue that 
bot)l upstream and +1 species are RNA polymerase II 
products, although this has not yet been determined directly. 
The RNAs produced from the two classes of transcription 
have distinct patterns of tissue-specific expression, implying 
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significant developmental regulation of the cnoice between 
TATA-independent and TATA~dependent transcription. 
While the + 1 transcript constitutes the bulk of MT-1 RNA in 
most cell types, in the late meiotic and postmeiotic cells of 
the testis the TAT A-independent transcripts are the predom-
inant MT-I RNA species. In addition, cell types differ in the 
specific sets of TAT A-independent RNAs that they contain, 
suggesting an additionallevel.~f tissue specificity beyond the 
choice of TAT A-independent versus TAT A-dependent initi-
ation. For example, approximately 60% of the TAT A-inde-
pendent RNAs in testis are group D, E, and F RNAs (Fig. 2), 
but these RNAs contribute only a minor fraction of TAT A-
independent RNAs in kidney· and L cells. The precise 
locations of the start sites differ · as well and fall into two 
patterns, one epitomized by testis (Fig. lC, lanes 1 and 2, 
and data not shown) and the other by .kidney (Fig. lC, lanes 
3 and 4, and data not shown). 
The TAT A-dependent and TATA-independent classes of 
RNA are also regulated differently by 'metal, which is known 
to increase the overall rate of transcription of the MT-I gene 
in many cell types (13). Thus, the choice of core promoter 
mechanism appears to be intimately linked with the gene' s 
metal inducibility. The +1 RNA is metal inducible in all 
cellular contexts examined except for the testis, which does 
not exhibit significant metal induction of any MT-I or MT-11 
RNAs. The TATA-independent RNAs are not induced by 
metal in any cellular context tested, nor do they become 
metal responsive in the case of a TATA-minus mutant 
assayed in cells in which the wild type MT-I gene is metal 
responsive. We favor the view that these differences in 
expression of MT-I RNAs are generated mainly at the 
transcriptional leveL However, in the absence of direct 
measurement of transcription initiation, we cannot exclude 
the possibility that any of these observations are substan-
tially due to posttranscriptional effects. For example, it is 
formally possible that preferential stabilization of the up-
stream RNAs in testis combined with efficient degradation of 
+1 RNAs in the same cells could give rise to the observed 
distribution of transcripts. Conversely, preferential destabi-
lization of upstream RNAs in response to metal could be 
invoked to explain the metal-refractory nature of the up-
stream RNAs. In the latter case, our studies of MT-I fusion 
genes show that such differential posttranscriptional effects 
would have to rely on nucleotides in the -1 to -12 region. 
Furthermore, these sequences would have to perform any 
posttranscriptional, metal-responsive function indepen-
dently of the MT-I sequences replaced by CAT in the 
transgenes. Such a scenario seems unduly perverse. 
The extent of interrelation between TAT A-dependent and 
TATA-independent transcriptional modes is an issue raised 
but not resolved by our observations. Closely related DNA-
protein complexes could activate both transcriptional 
modes, with a subset of components determining the balance 
and separate characteristics of TATA dependence and 
TATA independence. Alternatively, mutually exclusive 
complexes containing entirely different accessory factors 
could be used. The ability of promoters which normally 
appear to support little or no TAT A-independent transcrip, 
tion to function after TATA element removal (3, 5, 12; 17, 
19) and the ability ofSpl to stimulate both TAT A-dependent 
and TATA-independent transcription (14) argue that the 
switch to TAT A-independent transcription may not require 
wholesale remodeling of the transcription complex. 
It is interesting to consider this new information about 
MT-I promoter function in the context of what is kno\vn of 
its structure. The MT-I proximal regulatory.~egion contains __ 
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a number of cis-acting elements identified either genetically 
or by homology to known transcription factor-binding sites 
(Fig. 2B). These include several metal-responsive enhancer 
elements (MREs) (7, 49, 52) and potential binding sites for 
general transcription factors such as MLTF (8, 10, 46) and 
Spl (28). In vivo footprinting in L cells has detected DNA-
protein interactions at many of these sites, with only the 
MRE interactions dependent on metal treatment (39) (Fig. 
2B legend). The relevance of this current picture of MT-1 
DNA-transcription factor interactions to the TAT A-indepen-
dent mode of transcription is unknown, but it is of interest 
that the MREs directly overlap a number of the upstream 
start sites. Metal-dependent occupancy of these sites acti-
vates transcription only from the + 1 region, suggesting that 
they are either inappropriately positioned to activate up-
stream RNA synthesis or incompatible with the upstream 
initiation complexes. The MREs could also be responsible 
for the observed metal-induced decrease in upstream RNA 
in L cells. Factors bound to the MREs could suppress the 
use of the upstream start sites directly, by steric occlusion, 
or indirectly, by activation of the TATA-dependent tran-
scriptional mode at the expense of the TAT A-independent 
mode. 
Further investigation of these phenomena is likely to be 
difficult using L cells alone, considering the small amount of 
upstream RNA that they contain. However, an in vivo 
footprint study of the MT-1 gene in the pachytene cells of the 
testis together with analysis of site-directed mutants in the 
testes and other tissues of transgenic mice may provide 
further insight into regulation of this compound promoter. 
Ultimately, the MT-1 compound promoter should serve as a 
model system for in vitro reconstruction of promoter choice 
and for characterization of the specific protein interactions 
that account for the strongly preferential interaction of the 
metal response with TAT A-dependent initiation. 
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ABSTRACT We have developed a simplified procedure for 
the ligation-mediated polymerase chain reaction (LMPCR) 
using Thermococcus litoralis DNA polymerase (Vent DNA 
polymerase). We show that Vent DNA polymerase produces 
correct, blunt-ended primer extension products with substan-
tially higher efficiency than Thermus aqualicus (Taq) DNA 
polymerase or modified T7 DNA polymerase (Sequenase). This 
difference leads to significantly improved genomic sequencing, 
methylation analysis, and in vivo footprlntlng with LMPCR. 
These Improvements Include representation of all bands with 
more uniform Intensity, clear visualization of previously diffi-
cult regions of sequence, and reduction In the occurrence of 
spurious bands. It also simplifies the use of DNase I cut DNA 
for LMPCR footprintlng. · 
Footprinting experiments are commonly and productively 
used to study protein-DNA interactions and DNA config-
uration in vitro. Analogous in vivo experiments done on genes 
in the living ceil can bring a different and useful data set to the 
problem of gene expression, but they require special methods 
for visualizing the result. Direct genomic sequencing tech-
niques, which permit the examination of single-copy genes in 
large genomes, are being used increasingly for this purpose 
(1-4). Ligation-mediated PCR (LMPCR) is a recently intro-
duced method that substantially increases the absolute signal 
and the signal-to-noise ratio obtained for genomic sequencing 
(2, 5, 6). It does so by coupling PCR with genomic sequencing 
to provide specific amplification of a sequence "ladder," 
while preserving the identity and relative quantitative repre-
sentation of each rung in the original cleaved genomic DNA 
preparation. Its application has made in vivo footprinting (2) 
and chromosomal methylation analysis (6) more readily ac-
cessible for organisms with large genomes (e.g., mammals). 
While LMPCR has been used successfully by a number of 
investigators to obtain high quality in vivo footprint and 
methylation information (2, 6, 7, 8), it has had two problems 
that can significantly compromise data quality. These effects 
are minor in some regions of sequence but can be problematic 
in others. First, certain bands are consistently weak or 
missing in the genomic ladders. Second, "extra" bands 
occasionally appear in the genomic ladders. These bands, 
which aren't predicted from the sequence as independently 
determined from cloned DNA, are usually adjacent to ex-
pected bands and therefore convert some triplets into quar-
tets, some doublets into triplets, and so on. We present here 
a solution for these problems that also permits simplification 
of the LMPCR procedure. These improvements stem from 
the use of Tlrermococcus /itoralis DNA polymerase (Vent 
polymerase). This thermostable polymerase possesses no 
detectable terminal deoxynucleotidyltransferase activity un-
der our conditions, and this characteristic dramatically im-
The publication costs of this article were defrayed in part by page charge 
payment. This article must therefore be hereby marked "advertisement" 
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proves LMPCR genomic sequencing. For in vivo footprinting 
and genomic sequencing applications, Vent polymerase 
yields substantially superior results, improving overall signal 
and, most importantly, the quality of sequence in difficult 
regions. We also show that starting material possessing 
3'-hydroxyl ends (in this case DNase 1-cut DNA), which had 
required modification of template ends with dideoxynucle-
otides in the older form of LMPCR (9) , can now be used for 
in vivo footprinting purposes without modification. ' 
MATERIALS AND METHODS 
Cell Culture and DNA Preparation. L cells were grown in 
Duibecco's modified Eagle's ·medium with 10% undiaiyzed 
calf serum (Irvine) and 2 mM glutamine. Naked and in vivo 
dimethyl sulfate (DMS)-treated MM14 DNA was provided by 
P. Mueller. DNA samples for genomic sequencing and DMS 
footprinting were prepared as in refs. 10 and 11. In vivo 
DNase I treatment was as in ref. 12, except that cells were 
permeabilized on ice with lysolecithin (0.25 mg/ mi) for 60 
sec. Addition of dideoxynucleotides prior to LMPCR where 
noted was as in ref. 9. 
LMPCR. LMPCR using T7 DNA polymerase (Sequenase 
version 1.0; United States Biochemical) and Thermus aquat-
icus (Taq) DNA polymerase (AmpiiTaq ; Cetus) was done as 
in refs. 2 and 5. LMPCR using Thermococcus litoralis DNA 
polymerase (Vent; New England Bioiabs) was done as below. 
All solutions were chilled and manipulations were performed 
on ice except as noted. The pH values given are for room 
temperature. To 5 J.tl (2 J.tg) of DNA in TE (10 mM Tris·HCl, 
pH 7.5/ 1 mM EDTA) was added 25 J.tl of first-strand mix 
[1.2X first-strand buffer (48 mM NaCI/ 12 mM Tris·HCI, pH 
8.9/6 mM MgS04/ 0.012% gelatin) with 0.3 pmol of gene-
specific primer 1, 240 JLM each dNTP, and 1 unit of Vent 
polymerase]. First-strand synthesis used a thermal cycle of 5 
min at 95•c, 30 min at 6o•c, and 10 min at 76°C. The samples 
were immediately iced. (It is important to minimize Vent 
polymerase activity during the ligation step by keeping the 
sample cold.) Twenty microliters of dilution solution (110 
mM Tris·HCI, pH 7.5/18 mM MgCI2/50 mM dithiothreitol/ 
0.0125% bovine serum albumin) and 25 J.tl of ligation solution 
[10 mM MgCI2/20 mM dithiothreitol/3 mM ATP/ 0.005% 
bovine serum albumin with 100 pmoi of unidirectional linker 
in 250 mM Tris·HCl (pH 7.7) (thawed and added on ice) and 
4.5 units of T4 DNA ligase (Promega)] were added. After 
incubation for 12-16 hr at l7°C, samples were iced and 9.4 J.tl 
of precipitation solution (0.1% yeast tRNA/2.7 M sodium 
acetate, pH 7.0) and 220 ,~-tl of ethanol were added. The 
samples were placed at -2o•c for 2:2 hr and then spun for 15 
min at 4°C in a microcentrifuge. The pellets were washed witli 
75% ethanol and dried in a Speed-Vac rotary evaporator 
(Savant). Samples were resuspended in 70 J.tl of water at roon'i · 
Abbreviations: LMPCR, ligation-mediated polymerase chain reac-
tion; OMS, dimethyl sulfate; MCK, muscle creatine kinase. 
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temperature and placed on ice. After addition of 30 ~tl of 
amplification mix [3.33x amplification buffer (133 mM 
NaCI/67 mM Tris, pH 8.9/17 mM MgS04/0.03% gelatin/ 
0.3% Triton X-100) with 670 ~tM each dNTP, 10 pmol of 
gene-specific primer 2, and 10 pmol of linker primer 
LMPCR.l)] and 3 ~tl (3 units) of Vent polymerase, samples 
were overlaid with 90 ~tl mineral oil and subjected to PCR 
using 18 cycles of 1 min at 95•c, 2 min at 66•c, and 3 min at 
76•c, with these modifications: (i) first-round denaturation 
was 3.5 min at 95•c; (ii) 5 sec was added to the 76•c step with 
each successive cycle (e.g., second round, 3 min 5 sec at 
76•C); (iii) for cycle 18, the 76°C step was 10 min. Samples 
were then placed on ice and 5 ~tl of labeling mix [1 x 
amplification buffer with 2 mM each dNTP, 2.3 pmol of 
gene-specific primer 3 (end-labeled as in refs. 2 and 5), and 1 
unit of Vent polymerase) was added. The labeling cycle was 
3.5 min at 95•c, 2 min at 69•c, 10 min at 76•c, 1 min at 95•c, 
2 min at 69°C, and 10 min at 76°C. The reaction was stopped 
by placing the samples on ice and adding 300 ~tl of stop 
solution (10 mM Tris·HCl, pH 7.5/4 mM EDTA/260 mM 
sodium acetate, pH 7.0, containing tRNA at 67 ~tg/ml). 
Samples were shifted to room temperature and extracted with 
400 ~tl of phenol/chloroform/isoamyl alcohol (25:24:1, vol/ 
vol). The aqueous phase was split into four aliquots of 94 ~tl. 
and 235 ~tl of ethanol was added to each. Before electropho-
resis, samples were precipitated, washed, and dried as above. 
After resuspension in 7 ~tl of load dye (2, 5) and heating at 
8s•c for 5 min, samples were iced and then loaded on 6% 
polyacrylamide sequencing gel (2, 5). Loading one-fourth of 
an LMPCR mixture per lane yielded a strong signal on X-AR 
film (Kodak) after 3 hr with an intensifying screen at -8o•c 
or 12 hr with no screen at -2o•c. The unidirectional linker, 
linker primer, and muscle creatine kinase (MCK) oligonu-
cleotides were as in ref. 2. The sequences (5' to 3') of the 
metallothionein I oligonucleotides were GAGTTCTCG-
TAAACTCCAGAGCAGC (primer 1), CAGAGCAGCGAT-
AGGCCGTAATATC (primer 2), and AGCGATAGGCCG-
TAATATCGGGGAAAGC (primer 3). 
RESULTS AND DISCUSSION 
LMPCR (Fig. 1) relies on creation of a blunt end in the initial 
primer extension reaction to serve as a ligation substrate. 
Later, in the labeling reaction, precise blunt-end termination 
of the extension product is required. If the final labeling 
extensions stop short or add extra nontemplated bases, the 
result will be extraneous, inappropriate bands. In general, 
imperfect extension products may result from DNA poly-
merases adding a nontemplated additional base after creating 
a blunt end (referred to as terminal transferase activity) (13). 
Both polymerases commonly used for LMPCR display some 
terminal transferase activity. Sequenase, used in the first-
strand synthesis reaction, adds an extra base to =50% of its 
products. Taq, used in the PCR amplification and labeling 
steps, adds an extra base to "'95% of its products (P. Mueller 
and B.J.W., unpublished data). Such activity during the 
first-strand synthesis creates molecules unable to participate 
in the blunt-end ligation. Should this activity show sequence 
preference, it would lead to underrepresentation or even 
complete loss of specific bands in the final LMPCR product. 
Terminal transferase activity might also explain the origin of 
spurious "extra" bands in an LMPCR ladder. For example, 
a single band in a genomic sequencing ladder would appear 
as a doublet if some products of the labeling reaction acquired 
the extra base. We hypothesized that the terminal transferase 
activities of Sequenase and Taq were the major source of 
imperfect regions in LMPCR ladders and sought a DNA 
polymerase that lacks appreciable terminal transferase ac-
tivity. 
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Fto. 1. LMPCR. Gene-specific primer 1 is hybridized to appro-
priately cleaved genomic DNA and extended using a DNA polymer-
ase creating a blunt end (first-strand synthesis). This blunt end is 
ligated to a unidirectional linker of defined length and sequence with 
one blunt end (ligation reaction). This product is a substrate for PCR 
using gene-specific primer2, which hybridizes internally, and a linker 
primer (LMPCR.l), which hybridizes to the ligated sequence (ex-
ponential amplification reaction). An end-labeled gene-specific 
primer, primer 3, is used to visualize the LMPCR product. Asterisks 
mark steps requiring efficient blunt-end generation. Open circle 
represents radioactive 5'-labeling of primer 3. 
Vent DNA polymerase was tested in side by side compar-
isons with Sequenase and Taq DNA polymerase. The non-
coding strand of the mouse MCK enhancer was used (14, 15) 
because it contains runs of G residues that have been 
problematic in Sequenase/ Taq-based LMPCR. Mouse ge-
nomic DNA treated with DMS in vitro was used in the initial 
tests. Subsequent piperidine treatment gave G-specific cleav-
age (16), and LMPCR with MCK primers yielded the G-spe-
cific MCK sequence ladder. The activities of Taq DNA 
polymerase and Vent DNA polymerase were compared in the 
amplification and labeling stages ofLMPCR. The products of 
Vent-catalyzed amplification and labeling consistently mi-
grated more rapidly than those of Taq-catalyzed companion 
reactions by a one-base increment (Fig. 2). Since Taq is 
known to add an extra base to most of its products, we 
interpreted the migration shift as an indication that Vent 
lacked detectable terminal transferase activity and migp,t 
therefore be an excellent candidate to replace both Seque-
nase and Taq in LMPCR. <· · 
When Vent was compared with Sequenase in the first- · 
strand synthesis , the most obvious effect was that the yield 
of LMPCR product increased severalfold (Fig. 2). This is 
consistent with the creation of more blunt-ended molecules 
by Vent in the first-strand synthesis and confirms that ~his 







-;:-~~ ~ . -- -~ -
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FIG. 2. LMPCR polymerase comparison. Each reaction used 
MCK primers and 2J.LgofMM14cell DNA treated with OMS in vitro 
and piperidine cleaved. Sequence at left is taken from Fig. 3. Hatched 
and solid bars are discussed in text. Seq, Scquenase. 
step is suboptimal with Sequenase. More important, Vent 
first-strand synthesis allowed visualization of bands that 
were underrepresented or absent in Sequenase-based 
LMPCR (note especially the several runs of G in the MCK 
enhancer denoted by the black bars in Fig. 2). Also, all bands 
in the ladder were more even in intensity. This is consistent 
with Vent creating blunt ends at many different sequences 
with similar efficiency and suggests that Sequenase shows 
sequence bias in blunt-end production . In addition to the shift 
in migration, the use of Vent instead of Taq in the amplifi-
cation and labeling steps generated a sequencing ladder in 
which fewer spurious bands appeared. A good example is 
noted by the hatched bar in Fig. 2, where a known G triplet 
(15) appeared to be a quartet when Taq was used but resolved 
into the expected triplet when Vent was used. Thus, the use 
of Vent polymerase in LMPCR improved both the first-strand 
synthesis step and the amplification and labeling steps. 
Sequencing and Methylation. In LMPCR-based genomic 
sequencing, total genomic DNA is cleaved by the Maxam and 
Gilbert base-specific reactions (11, 16) and this cleaved DNA 
serves as the substrate for LMPCR. Fig. 3 shows compara-
tive genomic sequencing of the MCK enhancer done by either 
Sequenase/Taq-based or Vent-based LMPCR. Regions are 
noted where sequence determinations could not be made 
using Sequenase/Taq-based LMPCR (the published se-
quence is given at right). In the region noted at the bottom of 
Fig. 3, not only is aT residue missing (upper open triangle), 
but a C residue is rendered ambiguous by the presence of 
spurious bands in the G+ A and G lanes (lower open triangle). 
In the middle region, the lower two bases of a CTC triplet are 
of equal intensity in the C lane (open triangle, correct band) 
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Genomic Sequence 
2 6 7 8 
FIG. 3. LMPCR direct genomic sequencing method comparison. 
Each reaction used MCK primers and 2 J.Lg of MM14 cell DNA 
treated with the appropriate Maxam and Gilbert sequencing reagent 
in vitro and then cleaved with piperidine. Black bar and triangles arc 
discussed in text. Sequence at right was determined in ref. 15 from 
cloned DNA. An A residue reported in ref. 15 is here of near equal 
intensity in G and G+A lanes, so the sequence below the bar is given 
as GACGGG in agreement with determination from cloned DNA in 
ref. 14. -
due to a spurious band in the C lane (filled triangle). In each 
of these cases the Vent-based results are unambiguous. The 
extended G-rich regions (noted by the black bar) are even 
more dramatically improved by the use of Vent, though some 
ambiguity remains. 
The analysis of chromosomal methylation [which has been 
implicated in such phenomena as chromosomal imprinting 
(17) and X chromosome inactivation (18)] is also improved. 
The Maxam and Gilbert C and C+T reactions require that C 
residues be unmethylated to participate. Because only un-
methylated C residues appear in the sequence ladder, ge-
nomic sequencing provides both sequence and methylation 
information. The two adjacent cytosines in the G-rich region 
are represented well only with Vent-based LMPCR and the 
CTC triplet noted above appears to be a CCC triplet unless 
Vent-based LMPCR is used. Thus methylation information 
concerning these residues, which would have been either 
ambiguous or nonexistent using the older method, can now 
be clearly determined. It can be concluded from this exper-
iment that the C residues of the MCK enhancer are not · 
entirely methylated in MM14 cells, because they do appear in 
the ladder. However, the degree of partial methylation of any' " 
C residue can be determined only by a side-by-side compar-
ison with unmethylated control DNA; hence, methylation of 
some copies of the MCK enhancer would not be detected in 
this experiment. 
.; 
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DMS Footprinting. In vivo footprinting is an especially 
sensitive application of genomic sequencing because it fo-
cuses directly on the relative intensities of individual bands 
in different samples. This demands that the intensity of each 
band in the final sequence ladder reflect in a consistent 
manner its relative abundance in the population of starting 
material. Thus, spurious "extra" bands that comigrate with 
genuine bands can obscure the subtle quantitative changes 
that usually comprise a footprint. In addition, some very 
useful cleavage agents react with only a subset of bases. 
Visualization of all legitimate cleavage products is therefore 
important, because an area of protein-DNA interaction may 
contain only one or two differentially reactive sites. 
In vivo footprinting using OMS involves exposing intact 
cells to OMS, terminating the alkylation reaction, purifying the 
alkylated DNA, cleaving with piperidine, and comparing the 
resulting G-specific sequence ladder with one generated by 
exposing purified, naked DNA to OMS in vitro (4). Band 
intensity changes between samples reflect protein binding and 
any other changes in DNA structure that alter reactivity with 
OMS . Fig. 4 shows in vivo footprinting of the MCK enhancer, 
which is active in differentiated muscle cells (myocytes) but 
not in undifferentiated muscle precursor cells (myoblasts) (2, 
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14, 15). G-specific sequence ladders were derived from in vivo 
OMS treatment of undifferentiated MM14 myoblasts and 
differentiated MM14 myocytes and from in vitro DMS treat· 
ment of naked MM14 DNA. LMPCR was performed with 
either Sequenase or Vent first-strand synthesis followed by 
either Taq or Vent amplification and labeling. The footprint 
information derived from this experiment was consistent with 
that of previous LMPCR footpri~ts of the MCK enhancer (2). 
In the region shown, myocyte-specific footprints are noted at 
three regulatory elements that have previously been defined as 
important for function (reviewed in ref. 2). The biological 
implications of this pattern have been discussed (2), and we 
focus here on how the new methods affect in vivo footprint 
analysis. Vent-based LMPCR gives greater absolute signal, 
and interactions that are sometimes difficult to see using 
Sequenase/Taq-based LMPCR, such as those at MEF-2 and 
near MEF-1, are now more obvious. This improvement is the 
combined result of acquiring previously missing bands and 
eliminating extraneous bands. For footprinting purposes, it is 
vital that identical DNA samples yield identical LMPCR 
results so that quantitative differences between different DNA 
samples can be interpreted. Vent-based LMPCR yields highly 
reproducible results, as shown by the exact match between the 
OMS In Vivo Foot rint 
SEOUENASE SEOUENASE VENT VENT 1s t str and Polymer ase 
TAO VENT TAO VENT Amplif ication 
Pol mera se 
Nak MB MC Nak MB MC Nak MB MC Nak MB MC Nak MB DNA 
2 3 4 5 6 7 8 9 101112 1314 
FtG. 4. LMPCR DMS in vivo footprinting method comparison. Each reaction used MCK primers and 21-'g of MM14 cell DNA treated with 
DMS in vivo o r in vitro prior to piperidine cleavage. Naked (Nak) DNA was purified and then OMS-treated in vitro. Myoblast (MB) and myocyte 
(MC) DNA samples were from cultured cells treated with DMS. Binding sites indicated at right are described in ref. 2, where lgK is called K 
and MEF-2 is called A-rich. Overexposure of lanes 10- 14, required to see Innes 1- 3, obscures footprints apparent at nonsaturating exposures. 
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F IG. 5. Comparison of LMPCR of DNase !-digested DNA with 
(lanes 1 and 2) and without (lanes 3 and 4) prior dideoxynucleotide 
modification. Each reaction used metallothionein I primers and 2 fJ.g 
of in vivo DNase (-digested L-cell DNA (lanes 1 and 3, DNase I at 
37.5 fJ.g/ ml; lanes 2 and 4, 25 fJ.S/ ml). All lanes are from the same 
autoradiograph. 
ladders from independent LMPCRs using duplicate DNA 
samples (Fig. 4, lanes 10 and 13, lanes 11 and 14). The LMPCR 
improvements observed were not restricted to the MCK 
enhancer region shown. Similar results were obtained for the 
mouse metallothionein I promoter (unpublished data). 
DNase !-Cleaved Substrates. Beyond the issues of ladder 
quality, a separate limitation ofLMPCR had been an inability 
to use DNA possessing 3'-hydroxyl ends for in vivo foot-
printing from organisms with large genomes. Although OMS/ 
piperidine cleavage does not leave 3'-hydroxyl ends, other 
useful footprinting agents, such as DNase I, do. Riggs and 
coworkers were able to circumvent this problem by the 
addition of a dideoxynucleotide to the 3'-hydroxyl ends of 
DNase !-digested material prior to Sequenase/ Taq-based 
LMPCR (9) and have obtained in vivo footprints with DNase 
I (19). Though effective, the additional manipulations are 
time-consuming and in our hands have resulted in low 
recovery of input DNA. With the Vent-based protocol , 
unmodified in vivo DNase !-digested DNA samples yield 
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ladders similar in clarity and intensity to those from dideoxy-
nucleotide-modified DNA (Fig. 5). Thus the addition of a 
dideoxynucleotide prior to LMPCR of 3'-hydroxyl-
containing DNA is no longer necessary. The basis for this is 
not certain , but increased temperature (76°C versus 47.C) in 
the Vent-catalyzed first-strand synthesis reaction may be 
important. It may inhibit the priming of DNA synthesis by the 
enormous numbers of genomic DNA 3'-hydroxyl ends pres-
ent in the first-strand reaction, While still providing efficient 
extension from the hybridized, gene-specific oligonucleotide. 
The more uniform and efficient use of starting material in 
Vent-based LMPCR should allow the use of less sample DNA 
while still obtaining statistically significant results. Fluctua-
tions in band intensity due to sampling error occur when the 
population sampled is small (founder effect, as discussed in 
ref. 5). They can obscure sequence or be mistaken for a 
footprint. Improved efficiency in LMPCR reduces the po-
tential for founder-based artifacts in formerly problematic 
sequences. Although the favorable effects of the Vent-based 
LMPCR procedure can be readily explained by an absence of 
terminal transferase activity, that is not formally proved here. 
Whatever their mechanistic origin, the properties of Vent 
extension reactions reported here suggest that Vent poly-
merase may also be superior for other applications in which 
blunt-ended products are desired. 
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Abstract 
The interleukin-2 gene is transcribed exclusively in T cells in response to 
antigen stimulation. Despite its developmentally-restricted signal-dependent 
expression, its regulatory region contains multiple individual elements that 
could potentially drive IL-2 transcription in a much wider range of cell types 
and conditions. Here, in vivo footprinting has been used to determine the 
pattern of protein:DNA interactions at the IL-2 locus in EL4 T cells, which 
transcribe IL-2 in response to appropriate stimuli, and in an hematopoietic cell 
population which cannot be induced to make IL-2, the pre-mast cell line 32D. 
Parallel in vitro analyses show that all cell types examined possess nuclear 
factors that recognize elements within the IL-2 regulatory region. However, in 
vivo analysis shows no evidence of assembly of a pre-complex at the IL-2locus 
in EL4 cells prior to stimulation, which might serve as a lineage-specific 
marker at the IL-2locus. We also see no evidence of protein:DNA interactions 
at the IL-2 locus in the 32D pre-mast cells, and hence no evidence of active 
repression in a non-expressing cell type. Similarly no in vivo protein:DNA 
interactions were detected at IL-2 in the non-expressing L cell fibroblast line. 
Upon stimulation of EL4 T cells, a multi-factor complex assembled at the IL-2 
locus and transcription of IL-2 was induced. The sites recognized by proteins 
in vivo also recognized activities present in nuclear extracts from these cells. 
Stimulation of EL4 T cells in the presence of the immunosuppressant drug 
cyclosporin A (CsA) prevented a subset of the DNA-binding activities seen in 
nuclear extracts, however the in vivo effect of CsA-treatment was to entirely 
block establishment of the enhancer complex. Taken together these data 
indicate that proteins do not stably bind to the IL-2 promoter/enhancer in vivo 
until T-cell-specific, signal-dependent, CsA-sensitive events initiate the 
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coordinated binding of general and cell-specific factors. These observations 
suggest that a significant amount of the signal integration involved in IL-2 
induction is c~rried out at the level of DNA occupancy and that the observed 




Interleukin-2 (IL-2) is an important growth factor forT cells and B cells 
which is synthesized by a subset of T helper cells upon their activation by 
antigen recognition. The regulation of IL-2 production has been extensively 
studied not only because of its importance in mounting an immune response, 
but also as a paradigm for the induction of new gene expression in response to 
signal transduction pathways involved in T cell activation. Furthermore, IL-2 
induction can be specifically blocked by treatment with immunosuppressant 
drugs such as cyclosporin A (CsA). This aspect of IL-2 regulation has been 
extensively examined as a way of gaining a molecular understanding of the 
activity of these drugs. 
Much of the control of IL-2 production takes place at the transcriptional 
level (Kronke et al. 1985; Brorson et al. 1991; Ullman et al. 1990). The 
recognition of antigen by the T helper cell in the context of the appropriate 
antigen presenting cell initiates a signal transduction cascade which, among 
many other things, results in a rapid rise in intracellular calcium and an 
activation of protein kinase C (Rothenberg 1992). Within twenty minutes, in a 
process requiring protein synthesis, IL-2 transcription is induced (Shaw et al. 
1988). CsA blocks aspects of this signal transduction cascade and in so doing 
blocks IL-2 transcriptional induction. Recent evidence suggests that it does so, 
at least in part, through an inhibition of the calcium-calmodulin-dependent 
phosphatase calcineurin (O'Keefe et al. 1992; Clipstone and Crabtree 1992). 
Thus, IL-2 transcription is both developmentally-restricted (T cell specific) and 
signal-dependent (taking place only in activated T cells not treated with CsA). 
The mechanisms used to control a gene's transcription can vary greatly, 
but share a basic feature. All depend on multiple regulatory elements 
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flanking, and sometimes within, the coding region which interact with cellular 
sequence-specific DNA binding proteins. In turn, these factors directly or 
indirectly control the assembly and activity of the general RNA polymerase II 
machinery of the cell near that gene's transcriptional initiation site. Previous 
studies of the in vivo assembly of transcription complexes at the muscle 
creatine kinase (MCK) (Mueller and Wold 1989) and c-fos (Herrera et al. 1989) 
genes have shown that the mechanisms by which transcription is turned on in 
a signal-dependent fashion can be very different. In the case of the myocyte-
specific enhancer of the MCK gene, that enhancer is not occupied by major 
groove DNA-binding factors ·in the non-expressing myoblast. Upon the 
differentiation of myoblasts to myocytes, which is triggered by decreasing the 
levels of growth factors such as fibroblast growth factor in the culture medium, 
multiple regulatory factors bind to the enhancer and MCK transcription is 
activated. c-fos induction by epidermal growth factor treatment of serum-
starved fibroblasts is mediated through a serum responsive element (SRE). In 
stark contrast to the MCK case, the SRE is indistinguishably occupied by DNA-
binding regulatory factors both before and after induction. Thus, in the MCK 
case the first step in activation was the binding of proteins to the DNA whereas 
in the c-fos case proteins were already bound and it was their activities that 
were altered. In both of these cases determining the pattern of protein:DNA 
interactions at these regulatory regions in the living cell was important in 
determining the mechanisms used to control their gene's transcription. Similar 
mechanistic diversity can be imagined for controlling transcription in a cell-
type-restricted fashion. However, in most cases studied, such as MCK 
(Mueller and Wold 1989) and the immunoglobulin heavy chain enhancer 
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(Ephrussi et al. 1985), no protein:DNA interactions were detected in non-
expressing cell types. 
An additional commonality among diverse genes is that a functional 
transcriptional enhancer or silencer is composed of a number of individual 
factor binding sites (Thompson and McKnight 1992). These individual cis-
acting elements often differ from one another in their regulatory capacities 
when examined by themselves, e .g., one may function as a cell-type specific 
activator while another as a ubiquitous activator. However, when combined 
as they are in naturally occurring regulatory regions, they collaborate to 
generate large and specific effects which are quite distinct from a simple 
summing of parts. As shown in the MCK and c-fos examples above, knowing 
the degree to which occupancy of the regulatory region or the activity of 
bound factors is limiting is key to understanding the mechanisms controlling 
gene activation and inactivation. Thus, in addition to identifying and 
categorizing individual cis-elements by classical mutagenesis approaches and 
characterizing the presence of potential binding activities by in vitro 
biochemical assays, direct measurement of in vivo occupancy of these binding 
sites is needed, but is available for only a few genes. 
The 300 base pairs immediately upstream of the IL-2 transcriptional 
start site contain a minimal promoter I enhancer region sufficient to drive a 
reporter gene in an appropriate IL-2-type expression pattern (Ullman et al. 
1990). This DNA regulatory region contains multiple individual DNA 
regulatory elements of diverse character. The NF-AT element, of which two 
are present, binds a factor found only in activated T cells (Shaw et al. 1988) and 
when present in several copies confers expression largely restricted to 
activated T cells upon a reporter gene in a transgenic mouse (Verweij et al. 
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1990). The NF-x:B and AP-1 elements confer activation upon a reporter gene in 
stimulated, but not unstimulated T-cells (Brabletz et al. 1991). However, these 
elements recognize factors found in many cell types and are signal-responsive, 
but not cell-type-specific activating elements (Hentsch et al. 1992). The IL-2 
regulatory region also contains two CACCC motifs which bind a number of 
factors which are expressed constitutively and are not T-cell-restricted, and 
they likely act as constitutive, general elements (Chen and Rothenberg 1992). 
Finally, the IL-2 regulatory region contains a site, OCT /OAP40, which binds 
both the relatively ubiquitous octamer family proteins (Kamps et al. 1990; 
Hentsch et al. 1992), as well as the more restricted, stimulation-dependent 
OAP40 protein (Ullman et al. 1991). The OCT /OAP40 unit functions as a 
stimulated-T-cell-specific activator site, though the octamer component is 
capable of binding to DNA constitutively (Kamps et al. 1990; Brabletz et al. 
1991; Ullman et al. 1991). As a whole the IL-2 regulatory region drives 
expression in a stimulation-dependent, T-cell-restricted fashion. The reliance 
on interactions between multiple sites to create this pattern of transcription is 
evident in a number of mutational studies. Gross alterations, such as splitting 
the regulatory region approximately in half, left two halves that each contained 
multiple factor binding sites. However, these halves were unable to inducibly 
activate transcription alone, but dimerizing either half largely restored activity 
(Durand et al. 1988). Finer mutations which altered individual cis-elements, 
such as the NF-AT, AP-1 or OCT /OAP40 sites, led to between 4 and 20 fold 
decreases in expression (Novak et al. 1990; Jain et al. 1992; Durand et al. 1988). 
Taken together, these data suggest that there exists extensive functional 
collaboration between the diverse individual regulatory elements within the 
IL-2 regulatory region. But it does not indicate whether these collaborative 
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events occur largely at the level of DNA regulatory element occupancy or the 
ability to activate transcription. 
The IL-2 minimal promoter I enhancer region also confers upon a 
reporter gene the complete CsA sensitivity of the IL-2 gene (Mattila et al. 1990; 
Randak et al. 1990). The individual regulatory elements show a diversity of 
behavior (Mattila et al. 1990; Randak et al. 1990). The ability of the NF-AT and 
OCT /OAP40 elements to activate transcription of a reporter gene when 
multimerized is entirely blocked by CsA, whereas the ability of NF-KB to 
function in this way is only partially sensitive. The ability of the AP-1 element 
to function in these assays is insensitive to CsA. The factors which bind to the 
CACCC motifs in vitro appear insensitive as well (see below), however this 
element's transcriptional activating potential has not been examined. 
In this work, we investigate the mechanism used to control IL-2 
transcription, including the way in which the individual regulatory elements 
collaborate, by examining the pattern of protein:DNA interactions at the IL-2 
locus in living cells. We examine this in different cell-types: lineally related 
cells which can and cannot be induced to transcribe IL-2 as well as unrelated 
cell types which do not make IL-2. We also examine cells in whom induction 
of IL-2 transcription has been blocked by treatment with CsA. 
RESULTS: 
To examine the mechanisms used to turn on IL-2 transcription in T cells 
as well as mechanisms that may be used to keep it off in non-expressing cell 
types, we have determined the pattern of protein:DNA interactions at the IL-2 
locus in three different types of cells. EL4.El.F4 (EL4) thymoma cells were 
used as a model IL-2 producer cell type. Upon stimulation with the phorbol 
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ester 12-0-tetradecanoyl phorbol 13-acetate (TP A) and the calcium ionophore 
A23187, which mimic many of the physiological effects of antigen stimulation, 
EL4 T cells show many of the same gene induction events as antigen-activated 
T helper cells (Novak et al. 1990). This includes strong IL-2 transcriptional 
induction which is sensitive to CsA treatment (Randak et al. 1990). In addition, 
much of the extensive work on IL-2 regulation has been done in this cell type. 
To examine why the IL-2 gene is not expressed in other hematopoietic cell 
types, 32D pre-mast cells were chosen because they respond to TP A and 
ionophore stimulation with some of the same gene-induction responses as EL4 
T cells (Novak et al. 1990; Novak and Rothenberg 1990). However, they fail to 
induce IL-2. Finally, L cell fibroblasts were studied to examine mechanisms 
that may be used to keep the IL-2 gene off in non-hematopoietic cells (data not 
shown). RNase protection analysis was performed to confirm the expression 
pattern of IL-2 in the various cell populations (Fig. 1), using the same cell 
preparations analyzed in the in vitro DNA binding and in vivo footprinting 
experiments described below. 
Multiple factors that can bind sites in the IL-2 promoter/enhancer in vitro are present 
in the nuclei of cells that do and cells that do not express IL-2 . 
The presence of nuclear factors that can bind to the IL-2 
promoter I enhancer is a prerequisite for the assembly of a transcription 
complex on the IL-2 gene in vivo. To establish the availability of such factors, 
nuclear extracts were prepared from the same EL4 T cell and 32D pre-mast cell 
populations examined above. These nuclear extracts were then tested to 
determine whether they contained factors capable of binding to isolated sites 
in the IL-2 promoter I enhancer in vitro by using gel-mobility shift assays. The 
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binding activities detected in EL4 T cells (figure 2) can be put into three 
categories: constitutive, stimulation-dependent (inducible), and stimulation-
dependent but CsA sensitive. Oligonucleotides spanning the CACCC sites in 
the IL-2 promoter bound nuclear factors in extracts from all cell preparations 
(lanes 1 to 6). The most prominent CACCC activities were neither stimulation-
dependent nor CsA-sensitive. Similarly, the octamer binding activities in these 
cells were neither stimulation-dependent nor CsA sensitive (lanes 7 to 9). The 
proximal AP-1 site was bound by factors which were inducible, but were not 
CsA sensitive (lanes 10 to 12). By contrast, both the distal and proximal NF-AT 
binding sites, as seen previously by others, showed stimulation-dependent 
binding activity that was highly CsA sensitive (lanes 19 to 24). The NF-KB site 
bound inducible factors whose binding activity, under our conditions, was also 
much reduced by CsA (lanes 16 to 18). Finally, the newly identified TGGGC 
element (see below) bound inducible activities with partial CsA-sensitivity 
(lanes 13 to 15). Thus multiple DNA-binding factors are present in the nuclei 
of unstimulated, stimulated, and CsA-treated stimulated EL4 T cells, but the 
precise combination of nuclear factors that were present differed in a signal-
dependent and CsA-sensitive fashion. 
Similar assays were done to determine whether factors recognizing IL-2 
regulatory elements were also present in the 32D pre-mast cells (data not 
shown). Constitutive activities capable of binding the CACCC and octamer 
motifs, and TPA/ A23187-responsive activities that bound the NF-KB and 
TGGGC sites were present at levels comparable to those in EL4 T cells. 
However, factors recognizing the AP-1 site were much reduced in abundance 
and inducible activities recognizing NF-AT were undetectable. Taken 
together, these results show that the nuclei of all EL4 and 32D cell populations 
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examined contain multiple sequence-specific factors capable of binding to 
elements within the IL-2 regulatory region in vitro. However, the precise 
combination of nuclear factors that were present differed in a cell-type-specific, 
as well as signal-dependent, and CsA-sensitive fashion. 
Determining the pattern of protein: DNA interactions at the IL-2 locus in vivo 
To detect in vivo protein:DNA interactions, in vivo footprinting was 
performed by treating intact cells with the membrane permeable alkylating 
agent dimethyl sulfate (DMS) (Ephrussi et al. 1985). DMS detects proteins 
bound to DNA at G-residues in the major groove. Protein occupancy can 
protect individual G-residues within its recognition site from reaction with 
DMS or, occasionally, render additional G-residues within that site 
hypersensitive to DMS. After this in vivo alkylation with DMS, subsequent 
treatment with piperidine was used to produce DNA cleavage at the 
methylated G's. When appropriately visualized, this results in an in vivo G-
specific cleavage ladder. In parallel, unmodified DNA was purified from cells, 
deproteinized and this naked DNA was then treated with DMS in vitro and 
subsequently cleaved with piperidine. DMS footprints were revealed by 
comparing the in vivo G-specific cleavage ladders from different cell 
populations with each other and with the pattern of in vitro G-specific 
cleavage of naked DNA. The DMS footprints, consisting of protected G-
residues and associated G-hypersensitivities, were visualized by ligation 
mediated PCR (LMPCR) genomic footprinting (Mueller and Wold 1989) as 
described previously (Garrity and Wold 1992). 
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Stimulation of EL4 T cells results in the coordinated binding of multiple proteins to 
the IL-2 promoter/enhancer 
The pattern of in vivo protein:DNA interactions at the IL-2 locus was 
assessed by quantitatively comparing band intensities in different in vivo 
DMS-treated and naked DNA samples (Fig. 3A, 3B). First, note that many sites 
in the IL-2 promoter I enhancer showed footprints in EL4 T cells upon 
induction. Comparison of the G ladder generated from IL-2 transcribing, 
induced EL4 T cells (Fig. 3A lane 5, Fig. 3B lane 6) with the Gladder from the 
same cells prior to induction (uninduced EL4 T cells, Fig. 3A lane 4, Fig. 3B 
lane 5) revealed many differences in DMS reactivity. Each interaction, 
indicated at the right margin of the figures 3A and 3B and summarized in 
figure 4, involves just a few specific G residues, as expected for a DMS 
footprint. These footprints were highly reproducible in multiple, independent 
experiments. 
Each interaction corresponds to a sequence-specific binding activity that 
can be detected in vitro in an electrophoretic mobility shift assay, with the 
exception of one site not yet tested. In vivo footprints were found at previously 
identified NF-AT (both -280 and -135), AP-1 (-150), octamer/OAP40 (-70 to 
-85), and NF-KB (-200) recognition sites, all of which have been shown to be 
functionally important by cis-e~ement mutagenesis experiments (Serfling et al. 
1988; Ullman et al. 1991; Durand et al. 1988; Briegel et al. 1991; Jain et al. 1992). 
The in vivo footprinting also confirmed the occupancy of a CACCC site (-294) 
described elsewhere (Chen and Rothenberg 1992) and revealed interactions at 
two previously unidentified elements, a proximal CACCC motif ( -60) and a 
TGGGC site (-225). Each of these elements bound sequence-specific factors 
from nuclear extracts in vitro as demonstrated in figure 2. An additional 
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unanticipated interaction was detected at an ATGG site (-175), which has not 
yet been examined in vitro. Finally, an additional interaction was seen between 
the two IL-2 TATA boxes, which may reflect the assembly of the basic RNA 
polymerase II machinery in that region. Occupancy of all these sites was 
detectable after one hour of induction, was maximal by two hours, and 
persisted at maximal levels at least 10 hours (figure 3 and data not shown). 
Footprints at the distal NF-AT site, the NF-KB site, and the proximal AP-1 site 
after two and five hours of induction are shown in figure 5. 
Conversely, several other potential regulatory elements were not 
detectably occupied in the major groove in vivo. We failed to detect contacts at 
the G residues in the distal octamer motif at -255, the distal AP-1 motif at -180 
(16, 18), and the region 3' of the distal NF-AT core at -280 (3' NF-AT site). The 
counterparts of these elements in the human gene, though not perfectly 
homologous to the murine elements, have been shown to contribute to its 
function (Kamps et al. 1990; Jain et al. 1992; Thompson et al. 1992). In these 
cells, no clear evidence was found for the binding of factors to the CD28 
response element (CD28RE) either, although protection was seen at the 
junction of this site with the proximal AP-1 site. This interpretation is 
consistent with the observation that the CD28RE plays no role in IL-2 
induction in response to TP A+A23187 induction in the human Jurkat T cell line 
(Fraser et al. 1992). Though in vivo footprints were performed up to 24 hours 
after induction (data not shown), no interactions were detected at the G 
residues in the putative negative element at -105, proposed to decrease 
induced transcription of the human IL-2 gene by functioning to shut off IL-2 
transcription at later time points (Williams et al. 1991). Thus, for several 
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potential regulatory elements we see no in vivo evidence that they play a role in 
IL-2 transcriptional regulation in mouse EL4 T cells. 
No protein:DNA interactions can be detected in unstimulated EL4 T cells, 32D pre-
mast or L cells 
In principle, cells that are not transcribing IL-2 might have stably bound 
repressors at the IL-2 locus or partially assembled enhancer complexes. 
Furthermore, a developmentally committed, but as yet uninduced IL-2 
producer, such an EL4 T cell, might reveal its committed status in the form of a 
different pattern of protein:DNA interaction than an IL-2 non-producer, such 
as a 32D cell or L cell. However, we detected no in vivo protein:DNA 
interactions in any of the non-expressing cells examined (unstimulated EL4 T 
cells, both stimulated and unstimulated 32D cells, and L cells [data not 
shown]). This conclusion was drawn by comparing the G ladders derived 
from naked DNA samples with those from in vivo samples. The naked DNA 
samples (Fig. 3A lane 3, Fig. 3B lanes 1 and 4) were very similar to the in vivo 
samples from cells not expressing IL-2 (Fig. 3A, lanes 1, 2, and 4, Fig. 3B lanes 
2, 3, and 5) (20). Particularly illuminating is inspection of the sites that showed 
extensive protein:DNA interactions in the induced EL4 cells. This clearly 
shows that the set of protein: DNA interactions present in that IL-2 transcribing 
cell are completely absent from the cells that do not express IL-2. The absence 
of detectable in vivo interactions contrasts with the presence of corresponding 
DNA-binding activities in the nuclei of these cells. 
Several subtle differences in DMS reactivity between naked DNA 
samples and in vivo DMS-treated samples were observed on the coding strand 
near -100 and -200. Several G's, only on that strand, were 20% to 25% hyper-
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reactive in all the in vivo DMS-treated samples from non-expressing cells, but 
were not associated with the DMS protections that usually accompany 
protein:DNA interactions Such isolated hypersensitivities are often 
encountered in comparisons of naked DNA versus in vivo DM5-treated DNA 
and do not seem to correspond with any protein:DNA interactions (Mueller 
and Wold 1989; Kara and Glimcher 1991). 
CsA treatment entirely blocks protein:DNA interactions in stimulated EL4 cells 
IL-2 transcription is completely sensitive to CsA, whereas the individual 
regulatory elements essential for its transcription differ in their CsA-
sensitivity. This effect could occur either through a complete block of DNA 
occupancy or through the elimination of a sufficient subset of DNA-bound 
activators that transcription could not occur. When EL4 T cells were 
stimulated in the presence of CsA, .all protein:DNA interactions detected in 
induced EL4 T cells were absent (lanes 6 and 10). Thus, CsA blocks the in vivo 
binding of all the factors whose binding to the IL-2 regulatory region could be 
detected, despite affecting the in vitro DNA-binding activities of only a subset 
of factors. Therefore, at least one CsA-sensitive component of the EL4 
response is required for the coordinated binding of all factors. Furthermore, 
when EL4 T cells were induced for 2 hours, long enough to form a full complex 
(figure 5, data not shown), and then treated with CsA, all footprints were gone 
when protein: DNA interactions were examined 7 hours later (data not shown), 
a time point when the complex would otherwise have been present. Thus, 
CsA blocks both the establishment and the maintenance of the protein:DNA 
complex at the IL-2 promoter/enhancer. 
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The absence of in vivo protein: DNA interactions in cells that do not express IL-2 is 
gene specific 
The conclusion that unstimulated EL4 T cells, CsA-treated stimulated 
EL4 T cells, and 32D cells show none of the in vivo interactions characteristic of 
induced T cells required a positive control to show that the absence of IL-2 
footprints is gene specific and not a simple artifact of c.ell handling or 
footprinting manipulations. This was done by using the same DNA 
preparations to footprint another gene, metallothionein-1 (MT-1), which is 
expressed in all of these cell populations (Fig. 1). Figure 6 shows that the 
characteristic in vivo footprint at the MT-1 locus SP1 site is present in all 
samples (compare in vivo lanes 2, 3, 5, 6 and 7 with in vitro DMS lanes 1 and 4). 
DISCUSSION: 
We have shown that EL4 T cell induction results in the coordinated 
assembly of a protein:DNA complex at the IL-2 promoter/enhancer in vivo (see 
figure 7). We saw no preassembly of the available subset of factors on the 
regulatory region prior to the cell receiving the inducing signal. Such 
preassembly would be indicative of transcriptional activation acting as the 
limiting step. In contrast, upon EL4 T cell stimulation, we saw the coordinated 
binding of multiple factors to the previously unoccupied IL-2 regulatory 
region, implicating the regulation of DNA occupancy as an important limiting 
step in IL-2 transcriptional activation. CsA has been shown previously to 
block the in vitro binding of factors sites which are important for the 
transcriptional activity of IL-2 in vivo. Our data show that CsA works through 
these sites by preventing the occupancy of not just these, but all the other 
factor binding sites that have been detected in vivo. 
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No in vivo protein:DNA interactions were detected in cells which were 
not transcribing IL-2, whether the cells were of hematopoietic or non-
hematopoietic lineage. Our observations do not rule out the possibility of 
repressive interactions to which DMS was insensitive, such as binding of 
proteins in the minor groove or to recognition sites devoid of G residues. 
Nonetheless, in non-expressing cells we see no in vivo evidence of proteins 
bound to sites that become detectably occupied by activator proteins in IL-2 
expressing cells. This argues quite strongly against competition between 
activator and repressor proteins for binding site contacts in the major groove 
(of the type prominent in the eve enhancer elements of Drosophila, for 
example) (Small et al. 1992) as a way of enforcing cell-type and signal-
dependent restriction of IL-2 in these cells. 
Multiple factors capable of recognizing individual elements in the IL-2 
enhancer I promoter were detected in the nuclei of all cell types and 
physiological states examined (Figure 7). It is clear that the presence of a 
subset of factors alone is not sufficient to allow them to stably occupy their 
binding sites in the IL-2 gene in vivo. For example, the CACCC and octamer 
sites are occupied in vivo only in the IL-2 transcribing cells, though 
corresponding binding activities are present in nuclear extracts constitutively. 
Upon EL4 T cell stimulation binding activities appear which recognize 
additional cis-elements. Even when the stimulation is performed in the 
presence of CsA some of these inducible DNA-binding activities, such as AP-1, 
still appear. However, the binding sites for these CsA-resistant factors remain 
unoccupied. One interpretation of this is that inducible, CsA-sensitive factors 
such as NF-AT(and possibly the OAP40/0CT complex) play the limiting roles 
in nucleating DNA:protein complex assembly in EL4 T cells. In considering 
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the absence of in vivo footprints in 32D cells, it is formally possible that the IL-2 
locus is permanently shut down in a cell line destined never to make IL-2 
using a mechanism that may not reflect normal developmental processes. 
However, the presence in these cells after induction of most, but not all (e.g., 
AP-1, NF-AT) of the activities found in induced EL4 T cells is consistent with 
the idea that key factors such as NF-AT are required for DNA:protein complex 
assembly. 
The specific regulatory activities attributable to the newly identified 
TGGGC and proximal CACCC elements can be addressed in part by 
reexamining previously published deletion mutant studies. A series of 5' 
deletion constructs of the mouse IL-2 gene experienced a 5 fold drop in 
inducibility in EL4 cells when 36 bp including the TGGGC motif were 
eliminated (Serfling et al. 1988). This region contains no other element which 
showed an in vivo interaction. An internal deletion across the proximal 
CACCC motif in the human IL-2 gene decreased activity of the otherwise 
intact enhancer 5-fold, though this deletion is positioned next to the TATA 
boxes, and alterations in spacing could have contributed to this effect (Durand 
et al. 1988). Thus the newly identified elements appear to contribute to IL-2 
expression. 
Two models, which are not mutually exclusive, could explain the 
coordinated binding seen at IL-2 in vivo: cooperative binding or limited site 
accessibility. Cooperative binding interactions between the multiple DNA-
binding proteins that can interact with individual cis-elements, perhaps 
anchored by a few key factors, could stabilize the binding of each member of 
the complex. Such cooperativity could operate through direct interactions of 
the DNA-binding factors with each other as well as through additional, as yet 
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unidentified proteins which would act through protein:protein interactions 
with the DNA-binding factors. Inducible, T-cell specific, CsA sensitive factors 
would be limiting for stable complex assembly. For IL-2, one cooperative 
interaction has been documented at the OAP40/0CT element where 
cooccupancy by OAP40 and oct-1 stabilizes the binding of oct-1 (Ullman et al. 
1991). It will now be important to look for such interactions between the 
multiple elements in IL-2. 
Regulated site accessibility is envisioned to involve the masking of 
potential binding sites near IL-2 in a repressed chromatin configuration. For 
example, in the mouse mammary tumor virus promoter it has been shown that 
the binding of glucocorticoid receptor to DNA assembled in a nucleosome 
facilitates the binding of NF-1 to its nearby binding site by rendering the NF-1 
site accessible to its factor (Archer et al. 1991; Archer et al. 1992). In the case of 
IL-2, the action of inducible factors could similarly serve to open the region 
allowing all the proteins to interact with their binding sites. For either model, 
our observations that CsA treatment apparently blocks both the establishment 
and the maintenance of the enhancer complex highlight the CsA-sensitive 
factors as candidates for a chromatin opening function and/ or for nucleating 
cooperative occupancy. 
IL-2 is synthesized as a result of the T cell integrating multiple internal 
and external signals. We have demonstrated that stimulation of EL4 T cells 
triggers the coordinated occupancy of the IL-2 regulatory region and that CsA 
totally blocks this coordinated occupancy of the complete regulatory region in 
vivo despite affecting the ability of only a subset of factors to recognize their 
isolated bl.nding sites in vitro. Together these observations both provide 
evidence that a significant amount of the signal integration involved in IL-2 
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induction is carried out at the level of DNA occupancy and that the observed 
multi-component, coordinated assembly is an essential component of this 
integrative process. 
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MATERIALS AND METHODS: 
Cell culture 
EL4.El.F4 thymoma cells and 32D pre-mast cells were grown as described in 
(Novak and Rothenberg 1990) and L cells as described in (Garrity and Wold 
1992). EL4 cells and 32D cells were induced using 10 ng/ml TP A and 180 nM 
A23187. When inductions were performed in the presence of CsA, it was used 
at a concentration of 0.51J,g/ml. 
RNA preparation and measurements 
Total RNA was prepared by .the guanidinium isothiocyanate/ organic 
extraction method of (Chomczynski and Saachi 1987) and RNase protection 
analysis performed as previously described (McGuire and Rothenberg 1987; 
Miner and Wold 1991). RNA probes were as previously described for IL-2 
(McGuire et aL 1988), MT-I (Mueller et al. 1988), and GAPDH (Tavtigian 1992). 
51J,g of total RNA were used in the IL-2 analysis, 1 )..lg in the MT-I analysis, and 
1 )..lg in the GAPDH analysis. 
In vivo and in vitro DMS/piperidine treatment of DNA 
Adherent L cells were treated as described in (Mueller et al. 1988). EU 
and 32D suspension cells in media (107 to 108 in 50 ml) were pelleted at 500 g 
for 5 min at room temperature. Sufficient media was left behind to allow 
resuspension of the cell pellet in a final volume of 1 ml. Cells were transferred 
to a 1.5 ml microcentrifuge tube and placed in a 3TC water bath. 10)..ll of a 
freshly made 10% DMS I 90% ethanol solution were added and the sample 
was mixed by gentle inversion. After incubation at 37•c for 1 minute, cells 
were transferred to a tube containing 49 ml of ice-cold phosphate buffered 
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saline (PBS) and centrifuged at 500g for 5 min. at 4°C. The cell pellet was 
resuspended by gentle pipetting in 1 ml ice-cold PBS, 49 ml of additional ice-
cold PBS were added, and the sample was centrifuged at 500g for 5 min. at 4 OC. 
The cell pellet was resuspended in 0.3 ml ice-cold PBS, then added to 2.7 ml of 
lysis solution (300mM sodium chloride, 50mM Tris pH 8.0, 25 mM EDTA pH 
8.0, 200Jlg/ml proteinase K, 0.2% SDS). DNA was prepared as described in 
(Mueller et al. 1988). Naked DNA preparation and in vitro DMS treatment was 
as in (Mueller et al. 1988) except 0.125% DMS for 2 minutes at room 
temperature was used. Subsequent piperidine cleavage was as in (Mueller et 
al. 1988). 
Ligation-mediated PCR visualization of genomic footprints 
LMPCR-aided DMS in vivo footprinting was carried out as detailed in 
(Garrity and Wold 1992). Oligonucleotides used in the LMPCR to detect 
interactions on the non-coding strand of IL-2 oligonucleotides were: primer 1) 
CTATCTCCTCTTGCGTTTGTCCACC; primer 2) TGTCCACCACAACAGG-
CTGCTT ACAGGT; primer 3) CACCACAACAGGCTGCTTACAGGTTCAG-
GATG. Coding strand IL-2 oligonucleotides were: primer 1) GGACTTGAG-
GTCACTGTGAGGAGTG; primer 2) CAAGGGTGATAGGCAGCTCTTCAG-
CATG; primer 3) CAAGGGTGATAGGCAGCTCTTCAGCATGGGAG. 
LMPCR hybridization temperatures for both primer sets were: primer 1, 60oC; 
primer 2, 69°C; primer 3, 72°C. The coding strand MT-1 oligonucleotides were: 
primer 1) CGGAGTAAGTGAG-GAGAAGGTACTC; primer 2) GGAGAAG-
GTACTCAGGACGTTGAAG; primer 3) GAAGGTACTCAGGACGTTGA-
AGTCGTGG. LMPCR hybridization temperatures were: primer 1, 60°C; 
primer 2, 66oC; primer 3, 69oC. 
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Quantitation of band intensity was performed using an LKB UltroScan 
XL laser densitometer and recording peak heights. Fixed and dried 
footprinting gels were exposed to XAR-5 film without Saran-Wrap or an 
intensifying screen. Multiple exposures of two entirely separate in vivo 
footprint experiments were examined, using three separate scans for each lane. 
Protections and hypersensitivities indicated ranged in intensity from 25% to 
65% protection and from 25% to two-fold hypersensitivity in the induced EL4 
cell samples compared to both naked DNA samples and uninduced EL4 cell 
samples and were observed in both experiments. Several G residues on the 
coding strand near -100 and -200 were between 20% and 25% hyper-reactive in 
all in vivo samples from non-expressing cells. 
Electrophoretic mobility shift assays 
Nuclear extracts were prepared as described (Stein et al. 1989) from the 
same cell populations used in the in vivo footprinting experiments. The 
mobility shift assay was performed as described in (Chen and Rothenberg 
1992) using 5 J.lg nuclear extract, 0.5 J.lg poly (dl-dC), and approx. 5 fmol of the 
appropriate 32P-labeled oligonucleotide. Oligonucleotides were labeled by 
end-filling with Klenow polymerase. The sequence of one strand is given for 
each oligonucleotide used (bases not present in the IL-2 gene are lower case): 
distal CACCC ( -300 I -278): gatcTCTCCACCCCAAAGAGGAAAATTgatc; 
proximal CACCC ( -721 -52): gatcACATCGTGACACCCCCATATTgatc; 
octamer ( -100 I -69): gatcTCTTTGAAAATATGTGTAATATGT AAAACATgatc; 
AP-1 (-1611-143): AATTCCAGAGAGTCATCAG; TGGGC (-237 l-218): 
gatcCCACCTAAGTG-TGGGCTAACgatc; NF-KB (-2111-192): AAGAGGGAT-
TTCACCTAAAT; distal NF-AT (-2891-260): AAGAGGAAAATTTGTTTC-
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FIGURE 1: RNase protection analysis of interleukin-2 (IL-2), metallothionein-1 
(MT-1), and glyceraldehyde 3-phosphate dehydrogenase (GAPOH) transcripts 
in RNA from the in vivo footprinted cell populations. RNA from unstimulated 
EL4 cells (lane 1), EL4 cells stimulated for 7 hours with 10 ng/ml TPA and 180 
nM A23187 (lane 2), EL4 cells stimulated for 7 hours in the presence of 0.5 
IJ,g/ml CsA (lane 3), unstimulated 320 cells (lane 4), and 320 cells stimulated 
with 10 ng/ml TPA and 180 nM A23187 for 2 hours (lane 5) was used. IL-2 
RNA was also easily detected using RNA from EL4 cells stimulated for 2 hours 
(data not shown). Lane 6 contained only 30!-lg of tRNA. 5 IJ,g of total RNA 
plus 301J,g of tRNA were used in the IL-2 analysis, 1 IJ,g plus 301J,g of tRNA in 
the MT-1 analysis, and 1 J.lg plus 30J.lg of tRNA in the GAPDH analysis. 
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FIGURE 2: Characterization of nuclear factors present in EL4 cells by 
electrophoretic mobility shift assay. Nuclear extracts were prepared from the 
same cell populations used in the in vivo footprinting experiments. The 32p_ 
labeled oligonucleotide used in each experiment is indicated at the top of each 
panel. Arrowheads and brackets mark the major binding activities, as 
discussed in the text. The major complex for either CACCC motif can be 
competed by the oligonucleotide containing the other CACCC motif or, even 
more efficiently, by a consensus SP1 oligonucleotide (8, data not shown). The 
unmarked, inducible lower complex in lane 2 can be competed by the distal 
NF-AT oligonucleotide and likely represents binding of factors to the portion 
of the distal NF-A T site present in the distal CACCC oligonucleotide. 
Additional, faster migrating complexes was detected in lanes 4 to 6. None 
were CsA sensitive, and the most prevalent species was constitutively 
expressed. In lanes 7 to 9, OAP40 binding activity could not be detected in 
these experiments, likely due to the abundance of octamer binding species in 
EL4 cell extracts. In lanes 16 to 18, a faster migrating, minor NF-KB site 
binding species was detected which was inducible and partially CsA-sensitive 
like the major species. In lanes 19 to 24, in addition to the well-characterized, 
inducible, CsA-sensitive NF-AT complex (filled arrowheads), a faster 
migrating species with similar regulatory features (open arrowheads) was 
observed for both NF-AT sites. Additional, constitutive NF-AT motif binding 




























































































































































































FIGURE 3: DMS in vivo footprint of the IL-2 regulatory region. DNA from in 
vivo DMS-treated unstimulated 32D cells (panel A, lane 1; panel B, lane 2), 
stimulated 32D cells (panel A, lane 2; panel B, lane 3), unstimulated EL4 cells 
(panel A, lane 4; panel B, lane 5), stimulated EL4 cells (panel A, lane 5; panel B, 
lane 6), and EL4 cells stimulated in the presence of CsA (panel A, lane 6; panel 
B, lane 7) was used. Naked 32D DNA (panel B, lane 1) and naked EL4 DNA 
(panel A, lane 4, panel B lane 3), each treated with DMS in vitro, were also 
used. A) shows the in vivo footprint pattern of the coding strand and B) the in 
vivo footprint pattern of the non-coding strand. The position in the sequence 
ladder with respect to the major start site of IL-2 transcription is indicated on 
the left hand side of each panel. Noted on the right-hand side are bands which 
were reproducibly more than 25% protected or more than 25% hypersensitive 
in induced EL4 cells when compared to uninduced EL4 cells and to naked EL4 
DNA. Arrows mark protections and arrows with a circle at the end mark 
hypersensitivities. Certain weak interactions apparent in the experiment 
shown were not marked (e.g., a protection near -100 on the coding strand) as 
they were not reproducibly observed over the multiple independent 
experiments performed. An artifactual band not predicted from the primary 
sequence of IL-2 is marked with an asterisk and is specific for the non-coding 
strand primer set. It became 5 to ten-fold more intense than any other band in 
the ladder under LMPCR conditions which gave generally high background 
(using excess Vent polymerase or hybridization temperatures that were too 
low, data not shown). Its intensity correlated in no way with the identity of 
the DNA being used, but, instead, with the intensity of an apparent 
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FIGURE 4: Summary of in vivo protein:DNA interactions detected in 
stimulated EL4 T cells. Guanines protected from reaction with DMS in 
stimulated EL4 T cells are indicated by downward pointing arrows and 
guanines made hypersensitive to DMS in stimulated EL4 T cells are indicated 


































































































































































































































































































































































































































































































FIGURE 5: DMS in vivo footprints over representative binding sites at 2 hours 
and 5 hours of induction. DNA from in vivo OMS-treated uninduced EL4 cells 
(lane 1), EL4 cells induced for 2 hours (lane 2), and EL4 cells induced for 5 
hours (lane 3) was used. The entire set of interactions shown in figure 2 were 
seen in this experiment. All were of equal intensity in both induced samples, 
but only a subset are shown here to conserve space. Lane 2 was exposed for 
20% longer than lanes 1 and 3 to compensate for underloading of that lane. 
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FIGURE 6: DMS in vivo footprint of the SPl binding site in the 
metallothionein-1 (MT-1) gene. DNA from in vivo OMS-treated unstimulated 
32D cells (lane 2), stimulated 32D cells (lane 3), unstimulated EL4 cells (lane 5), 
stimulated EL4 cells (lane 6), and EL4 cells stimulated in the presence of CsA 
(lane 7) was used. Naked 32D DNA (lane 1) and naked EL4 DNA (lane 3), 
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FIGURE 7: Summary of the protein:DNA interactions detected EL4 T cells by 
in vivo footprint analysis and the presence of nuclear factors in these cells as 
determined through in vitro DNA-binding analysis. The decreased size of the 
TGGGC and NF-KB recognizing activities in stimulated, CsA-treated EL4 T 
cells signifies the quantitative decrease in in vitro DNA-binding activity seen in 
nuclear extracts from these cells in figure 2. Though OAP40 binding activity 
could not be detected in figure 2, its presence in stimulated EL4 cells was 
inferred because of the in vivo methylation protection of a guanine residue 
adjacent to the octamer site which specifically disrupts OAP40 binding when 
methylated (Ullman et al. 1991). Stimulation-dependent OAP40 binding 
activity has been detected in the human Jurkat T cell line, but its CsA 
sensitivity was not examined (Ullman et al. 1991). Binding of a specific-factor 



































































































































































In vivo footprinting of the myocyte-specific 
promoter of the nicotinic 8-AChR 
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INTRODUCTION: 
The delta-subunit of the nicotinic acetylcholine receptor (8-AChR) is 
specifically expressed in differentiated skeletal muscle cells. The region 
between 148 bp upstream and 24 bp downstream of the start site of 
transcription of the 8-AChR gene contains a minimal enhancer /promoter 
region which is sufficient to drive a reporter gene in the appropriate pattern of 
cell-type-specific expression (Baldwin and Burden 1988): C2C12 myoblasts 
stably transformed with this promoter/reporter fusion show a greater than 
100-fold increase in expression of the reporter upon differentiation (Baldwin 
and Burden 1988). This parallels the increase in 8-AChR RNA in these cells 
upon differentiation (Yu et al. 1986). As the promoter/reporter fusion RNA 
contained 24 nucleotides of 8-AChR RNA sequence, there was still a possibility 
of a large post-transcriptional component to this regulation. However, this 
region of the rat 8-AChR promoter, which is approximately 90% homologous 
to the mouse promoter, supports differentiated skeletal muscle-specific 
expression in C2C12 cells when only 4 nucleotides of 8-AChR RNA sequence 
are included in the reporter RNA (Chahine et al. 1992). Thus, it seems certain 
that the expression pattern of the reporter constructs are regulated at the 
transcriptional level and that the 8-AChR promoter activates transcription only 
in differentiated myocytes. · 
The structure of the 8-AChR DNA regulatory region has several 
characteristics that make it an interesting target for an analysis of the 
mechanism used in its transcriptional induction in vivo. It contains one 
binding site recognized in vitro by MyoD (the site is termed an E-box), but this 
site is located in the core promoter region 17 bp upstream of the transcriptional 
initiation site (Baldwin and Burden 1989). Most potential binding sites for 
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positively acting gene-specific regulatory factors are not located in the core 
promoter region, though in some cases repressors bind there and inhibit 
transcriptional initiation by directly competing with the general transcriptional 
apparatus of the cell for DNA-binding. However, theE-box, based on its role 
in a number of other regulatory regions functional in skeletal muscle 
(Weintraub et al. 1991), would naively be considered a site which would work 
to activate the expression of a gene such as B-AChR. I wanted to determine 
whether this element was occupied in vivo, and if so, whether it was occupied 
only in the myoblast, perhaps acting as a repressor, or only in the myocyte, 
where it might substitute for a TATA box. This was conceivable as the o-AChR 
core promoter possessed only a poor TATA homology, TAAA, in the TATA 
region. Instead of a clear TATA, however, the B-AChR core promoter region 
contained an initiator (Inr) element which is homologous at 8 of 8 positions to 
the Inr found in the terminal deoxynucleotidyl transferase (TdT) gene. The Inr 
element of the TdT can function by itself, without a TATA box, to fix the start 
site and direction of transcriptional initiation (Smale and Baltimore 1989). The 
Inr element functions by binding the general transcription factor TFII-I, which 
then recruits TFIID to the core promoter even in the absence of a functional 
TATA element (Roy et al. 1991). In addition, TFII-I has also been shown to be 
capable of interacting with E-boxes (Roy et al. 1991). I was interested in 
studying how the components of the rest of the DNA regulatory region would 
interact with the core promoter and what the pattern of occupancy of an Inr 
driven core promoter would be in vivo. Finally, I wanted to compare 
mechanisms by which this regulatory region was regulated with that of the 
muscle creatine kinase (MCK) enhancer, which shows the same pattern of 
transcriptional activity in these cells. Occupancy of the DNA regulatory region 
123 
by gene-specific regulatory factors appears to be the rate-limiting step in MCK 
enhancer function in these cells (Mueller and Wold 1989). It is show here that 
the o-AChR promoter is regulated in an entirely different fashion. 
RESULTS AND DISCUSSION: 
The pattern of in vivo protein:DNA interactions at the 0-AChR promoter 
was examined by dimethyl sulfate (OMS) in vivo footprinting as previously 
described (Garrity and Wold 1992) Two different mouse skeletal myoblast cell 
lines were examined, C2C12 and MM14. These two lines express many of the 
same proteins upon differentiation, though they express different 
combinations of the MyoD family of myogenic regulatory proteins. 
Proliferating C2C12 myoblasts express myf-5 and MyoD and, when 
differentiation is stimulated, myogenin and MRF-4 are also expressed (Mueller 
and Wold 1989; Miner and Wold, 1990). Proliferating MM14 myoblasts 
express only MyoD, and upon differentiation express myogenin as well 
(Mueller and Wold 1989; Miner and Wold, 1990). Thus, although both express 
many of the same skeletal muscle-specific proteins, the mechanism used to 
initiate their synthesis might be different in the two cell types. 
The pattern of in vivo protein:DNA interactions in these cell were first 
examined at the regulatory region of one constitutively expressed gene, the 
mouse metallothionein-1 promoter, and one regulatory region that is only 
active in differentiated muscle cells, the MCK enhancer. Footprints should be 
observed in all samples at the constitutively expressed MT-1 gene. This serves 
as a positive control to ensure that should a different regulatory region lack 
detectable interactions, the absence of interactions is gene-specific and hence 
not an artifact of the procedure. The examination of the MCK enhancer, which 
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functions only in differentiated C2C12 and MM14 cells, helps gauge the ability 
to see differences in interactions between the undifferentiated and 
differentiated cell types. The MM14 samples were previously examined at 
both the MT-I and MCK regulatory regions (Mueller and Wold 1989; Garrity 
and Wold 1992). As previously described, interactions were detected at the 
MT-I promoter in both myoblasts and myocytes, while interactions at the MCK 
enhancer were only detected in differentiated myocytes. The MT-I promoter 
and the MCK enhancer were also examined in the C2C12 samples and the 
patterns of protein:DNA interactions were both identical to those seen in the 
MM14 samples (data not shown). This indicates that protein:DNA interactions 
can be detected in all samples, and that the overall mechanism of activation of 
the MCK enhancer and the use of individual regulatory elements within the 
MCK enhancer are the same in both C2C12 and MM14 cells, even though they 
contain different combinations of MyoD family myogenic regulators. The 
MCK enhancer contains two E-boxes which are occupied by each of the 
members of the MyoD family in vitro and which are occupied in vivo (Mueller 
and Wold 1989). Either a common member of the MyoD family, such as 
myogenin, recognizes these elements in both cell types or different regulatory 
factors occupy the site indistinguishably in vivo. 
The pattern of in vivo protein:DNA interactions at the 8-AChR 
promoter were then characterized in these two cell types. G-residues on the 
coding strand from 25 bp downstream to beyond 250 bp upstream of the start 
site of transcription were examined for interactions as well as G-residues on 
the non-coding strand from 164 bp upstream to beyond 100 bp downstream of 
the start site of transcription. This covers the entire minimal promoter region 
and additional regions both upstream of the promoter and in the coding region 
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of the gene. Thus all the interactions at the minimal promoter and in the 
flanking regions that can be detected with DMS have been examined. Of the 
95 G-residues present in the 172 bp minimal promoter, in vivo interactions 
were detected at 26. Surprisingly, and in stark contrast to the pattern at the 
MCK enhancer in these cells, both MM14 myoblasts and MM14 myocytes 
showed multiple regions of occupancy (figure 1). The pattern of protein:DNA 
interactions was identical in intensity as well as in character in both myoblasts 
and myocytes in MM14 cells (figure 1). Identical results were obtained in 
C2C12 myoblasts and myocytes (data not shown). Furthermore, the pattern of 
interactions in C2C12 and MM14 cells were indistinguishable (figure 1 and 
data not shown). Thus the 8-AChR promoter activates transcription only in 
myocytes, though it appears to be identically occupied in both myoblasts and 
myocytes. Thus the induction of 8-AChR transcription is mediated by 
changing the activity of a complex that has already formed on its promoter. 
The observed protections are for the most part extremely strong, indicating 
that the complex has formed on the large majority of 8-AChR promoters in the 
population. No changes in the complex formed on the 8-AChR promoter were 
detected upon differentiation. However, there may be alterations in the 
pattern of protein:DNA interactions to which DMS is insensitive, such as 
minor groove interactions or binding of proteins to sites in which there are no 
G residues (though the latter is unlikely as the 8-AChR promoter contains no 
area with more than four consecutive A's and T's and only one with more than 
three). In addition, myocyte-specific proteins might replace myoblast-specific 
proteins without altering the DMS footprint. However, it is clear that there is a 
multiprotein complex assembled on the 8-AChR promoter prior to its 
activation. 
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Inspection of the pattern of DMS protection and enhancement seen in 
the comparison of naked muscle cell DNA treated with DMS in vitro and 
muscle cell DNA treated with DMS in vivo revealed three regions of 
protein:DNA interaction (MM14 in figure 1, C2C12 data not shown). One 
region of 20 bp extended from the downstream edge of the E-box, up to the 
TAAA site, and, though more weakly, to a position 4 bp upstream of the 
TAAA. A second set of interspersed interactions were detected over a 17 bp 
region centered near -60. A third set of interactions was detected near -100. 
This element contains a 9 for 9 match with a site in the human a-cardiac actin 
promoter. That site can recognize SP1 in vitro and in vivo (as shown by 
activation through SP1 expression in Drosophila cells), and is necessary but not 
sufficient for the muscle-specific activation of that promoter in collaboration an 
E-box and an element recognizing the serum response factor (Sartorelli et al. 
1990). This element is also homologous to the AP-2 element occupied in the 
MCK enhancer (Mueller and Wold 1989). Though there are six G-residues in 
the 10 bp surrounding the Inr element, no interactions can be detected at this 
site. TFII-I could recognize this site in vivo and escape detection in this assay if 
it bound exclusively in the minor groove or if by virtue of dissociating from the 
core promoter after every initiation event it effectively occupied this site only a 
small fraction of the time. Nonetheless, there is no evidence of its binding. In 
addition, there is no evidence for the binding of factors to the three TGGCCT 
motifs present between -108 and -148 which were shown to bind a myocyte-
specific factor in vitro (Baldwin and Burden 1989). No other interactions can be 
detected, either upstream of the minimal promoter nor in the coding region. 
These results show that the 8-AChR promoter is occupied by regulatory 
factors both prior to and after it is transcriptionally active. The pattern of 
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occupancy in the myoblast is indistinguishable from that in the myocyte. Thus 
the transcription of the o-AChR gene is not limited by the repressive effects of 
chromatin structure or the stable binding of factors to its regulatory region. 
Instead it is limited by the activity of the assembled DNA:protein complex. 
The E-box which overlaps its probably non-functional TATA-box is 
constitutively occupied. The large size of the region of contiguous occupancy 
suggests that multiple proteins bind adjacent to one another at this site. The 
nature of this complex and whether it may be functioning as a component of 
the core promoter, perhaps by interacting with TFII-1, or as an upstream 
regulator of initiation through the lnr, through binding of gene-specific factors 
such as MyoD, is an interesting, but currently unexplored question. The cell-
type distribution of this complex is currently unknown. Investigations in 
which the o-AChR locus is examined during myogenic conversion of non-
muscle cells with MyoD might suggest whether the assembly of this complex 
is a marker of myogenic commitment. More technically difficult, but 
ultimately most illuminating, would be the examination of this promoter in 
different populations of developing skeletal muscle cells from a developing 
mouse. We have examined the pattern of protein:DNA interactions in two 
cultured skeletal myoblast cell lines, C2C12 cells, in which transcription of the 
o-AChR gene has been shown to be activated in response to differentiation, 
and in MM14 cells, in which such experiments have not yet been performed. 
The identical in vivo footprint patterns in the two cell lines suggests that the 
promoter is functioning in a similar fashion in MM14 cells as well. However, 
only in the C2C12 cells can we be certain that the promoter is occupied before 
transcription is activated. 
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The absence of transcription from the assembled complex might reflect 
either an inability for the core promoter to assemble the general transcriptional 
machinery or the formation of inactive complexes of general factors, such as 
the inert TFIID /NC2 complexes observed in vitro (Meisterernst and Roeder 
1991). A paused polymerase is an unlikely explanation, as sequences in the 
transcribed region appear to mediate this function in other genes and the 
transcribed region of 8-AChR is not required for the differentiation-specificity 
of this promoter (Giardina et al. 1992; Chahine et al. 1992). Therefore, we have 
shown that the transcriptional activation of 8-AChR upon muscle 
differentiation occurs either through a replacement of factors bound at its 
promoter or through alterations in the ability of bound factors to activate 
transcription of this gene. 
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MATERIALS AND METHODS: 
Cell culture 
C2C12 cells were grown on collagen-coated tissue culture dishes in Dulbecco's 
modified Eagle's medium (DMEM) with 20% fetal bovine serum and 2 mM 
glutamine. Differentiation was initiated by feeding cells with switch medium 
(DMEM containing 2% horse serum and 2 mM glutamine). After 24 hours in 
switch medium cells were refed switch medium containing 1o-5M cytosine 
arabinoside and allowed to differentiate 48 hours more prior to in vivo 
footprinting. The MM14 DNA's were the gift of Paul Mueller. 
LMPCR 
LMPCR was performed using the conditions described in Garrity and Wold, 
1992. 8-AChR primers used were as follows: Non-coding strand primers: 1) 
AGAGGA TTCGCCCCCCACCCTCT; 2)ACCCTCTGCCACCCTACCCCACC-




I wish to thank Paul Mueller for his generous gift of MM14 DNA. 
130 
REFERENCES: 
Baldwin, T. J., and S. J. Burden. 1988. Isolation and characterization of the 
mouse acetylcholine receptor delta subunit gene: identification of a 148-
bp cis-acting region that confers myotube-specific expression. J. Cell. 
Bioi. 107: 2271-2279. 
Baldwin, T. J., and S. J. Burden. 1989. Muscle-specific gene expression 
controlled by a regulatory element lacking a MyoD1-binding site. 
Nature 341: 716-720. 
Chahine, K. G., W . Walke, and D. Goldman. 1992. A 102 base pair sequence of 
the nicotinic acetylcholine receptor delta-subunit gene confers 
regulation by muscle electrical activity. Devt. 115: 213-219. 
Garrity, P. A., and B. J. Wold. 1992. Effects of different DNA polymerases in 
ligation-mediated PCR: Enhanced genomic sequencing and in vivo 
footprinting. Proc. Natl. Acad. Sci. USA 89: 1021-1025. 
Giardina, C., M. Perez-Riba, and J. T. Lis. 1992. Promoter melting and TFIID 
complexes on Drosophila gene in vivo. Genes and Dev. 6: 2190-2200. 
Meisterernst, M., and R. G. Roeder. 1991. Family of proteins that interact with 
TFIID and regulate promoter activity. Cell67: 557-567. 
Miner, J. H., and B. J. Wold. 1990. Herculin, a fourth member of the MyoD 
family of myogenic regulatory genes. Proc. Natl. Acad. Sci. 87: 1089-1093 
Mueller, P. R., and B. Wold. 1989. In vivo footprinting of a muscle specific 
enhancer by ligation mediated PCR. Science 246: 780-786. 
Roy, A. L., M. Meisterernst, P. Pognonc, and R. G. Roeder. 1991. Cooperative 
interaction of an initiator-binding transcription initiation factors and the 
helix-loop-helix activator USF. Nature 354: 245-248. 
131 
Sartorelli, V., K. A. Webster, and L. Kedes. 1990. Muscle-specific expression of 
the cardiac a-actin gene requires MyoD1, CArG-box binding factor, and 
SPl. Genes and Dev. 4: 1811-1822. 
Smale, S. T., and D. Baltimore. 1989. The initiator as a transcriptional control 
element. Cell 57: 103-113. 
Weintraub, H., R. Davis, S. Tapscott, M. Thayer, M. Krause, R. Benezra, T. K. 
Blackwell, D. Turner, R. Rupp, S. Hollenberg, Y. Zhuang, and A. Lassar. 
1991. The MyoD gene family: nodal point during specification of the 
muscle cell lineage. Science 251: 761-766. 
Yu, L., R. J. LaPolla, and N . Davidson. 1986. Mouse muscle nicotinic 
acetylcholine receptor y-subunit: eDNA sequence and gene expression. 
Nucl. Acids Res. 14: 3539-3554. 
132 
FIGURE 1: Dimethyl sulfate (OMS) in vivo footprint of the 8-AChR regulatory 
region visualized by ligation mediated PCR performed on OMS-treated DNA 
samples. PANEL A: Lanes 1 through 3 show the pattern of OMS reactivity on 
the coding strand and lanes 4 through 6 show the pattern of OMS reactivity on 
the non-coding strand. Lanes 1 and 4 contained naked DNA, which was 
deproteinized and purified from MM14 cells prior to in vitro OMS treatment 
(Mueller and Wold, 1989). Lanes 2 and 5 contained DNA from MM14 
myoblasts treated with OMS in vivo. Lanes 3 and 6 contained DNA from 
MM14 myocytes treated with DMS in vivo. Sites of protein:DNA interaction 
are marked at the panel edge. PANEL B: Summary of in vivo protein:DNA 
interactions. Guanines protected from reaction with DMS in vivo are indicated 
by downward pointing arrow and guanines made hypersensitive to DMS in 
vivo are indicated by upward pointing arrows. Several adenines also appear to 
be hypersensitive in vivo. Though reproducible, the hyperreactive adenines are 
not included in the summary figure, as their relation to specific protein:DNA 
interactions has not been established (Mueller and Wold, 1989). Regions of 
protein:DNA interaction have boxes around them and were identified as 
described in the text. The potential Inr element is also indicated with a box. 
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